Document:

1999 Stock Incentive Plan, as amended

 Exhibit 10.12 
 SEQUENOM, INC. 
 1999 STOCK INCENTIVE PLAN 
 (Amended effective May 31, 2006) 
 (Following adoption of its 2006 Equity Incentive Plan on May 31, 2006 
 Sequenom discontinued equity awards under the
1999 Stock Incentive Plan 
 although such plan continued to govern outstanding awards under such plan) 
 (Share numbers set forth below have not been adjusted for the one-for-three 
 reverse stock split of its common stock that Sequenom implemented on June 1, 2006) 
 ARTICLE ONE 
 GENERAL PROVISIONS 
  

	I.	PURPOSE OF THE PLAN 

 This 1999 Stock Incentive Plan
is intended to promote the interests of Sequenom, Inc., a Delaware corporation, by providing eligible persons in the Corporation’s service with the opportunity to acquire a proprietary interest, or otherwise increase their proprietary interest,
in the Corporation as an incentive for them to remain in such service. 
 Capitalized terms shall have the meanings assigned to such terms in
the attached Appendix. 
  

	II.	STRUCTURE OF THE PLAN 

 A. The Plan shall be
divided into five separate equity incentive programs: 
  

	 	-	the Discretionary Option Grant Program under which eligible persons may, at the discretion of the Plan Administrator, be granted options to purchase shares of Common Stock,

  

	 	-	the Salary Investment Option Grant Program under which eligible employees may elect to have a portion of their base salary invested each year in special option grants,

  

	 	-	the Stock Issuance Program under which eligible persons may, at the discretion of the Plan Administrator, be issued shares of Common Stock directly, either through the immediate
purchase of such shares or as a bonus for services rendered the Corporation (or any Parent or Subsidiary), 

  

	 	-	the Automatic Option Grant Program under which eligible non-employee Board members shall automatically receive option grants at designated intervals over their period of continued
Board service, and 

  

 1. 

	 	-	the Director Fee Option Grant Program under which non- employee Board members may elect to have all or any portion of their annual retainer fee otherwise payable in cash applied to
a special stock option grant. 

 B. The provisions of Articles One and Seven shall apply to all equity programs under
the Plan and shall govern the interests of all persons under the Plan. 
  

	III.	ADMINISTRATION OF THE PLAN 

 A. The Primary
Committee shall have sole and exclusive authority to administer the Discretionary Option Grant and Stock Issuance Programs with respect to Section 16 Insiders. Administration of the Discretionary Option Grant and Stock Issuance Programs with
respect to all other persons eligible to participate in those programs may, at the Board’s discretion, be vested in the Primary Committee or a Secondary Committee, or the Board may retain the power to administer those programs with respect to
all such persons. However, any discretionary option grants or stock issuances for members of the Primary Committee must be authorized by a disinterested majority of the Board. 
 B. Members of the Primary Committee or any Secondary Committee shall serve for such period of time as the Board may determine and may be removed
by the Board at any time. The Board may also at any time terminate the functions of any Secondary Committee and reassume all powers and authority previously delegated to such committee. 
 C. Each Plan Administrator shall, within the scope of its administrative functions under the Plan, have full power and authority (subject to the
provisions of the Plan) to establish such rules and regulations as it may deem appropriate for proper administration of the Discretionary Option Grant and Stock Issuance Programs and to make such determinations under, and issue such interpretations
of, the provisions of those programs and any outstanding options or stock issuances thereunder as it may deem necessary or advisable. Decisions of the Plan Administrator within the scope of its administrative functions under the Plan shall be final
and binding on all parties who have an interest in the Discretionary Option Grant and Stock Issuance Programs under its jurisdiction or any stock option or stock issuance thereunder. 
 D. The Primary Committee shall have the sole and exclusive authority to determine which Section 16 Insiders and other highly compensated
Employees shall be eligible for participation in the Salary Investment Option Grant Program for one or more calendar years. However, all option grants under the Salary Investment Option Grant Program shall be made in accordance with the express
terms of that program, and the Primary Committee shall not exercise any discretionary functions with respect to the option grants made under that program. 
 E. Service on the Primary Committee or the Secondary Committee shall constitute service as a Board member, and members of each such committee shall accordingly be entitled to full indemnification and
reimbursement as Board members for their service on such committee. No member of the Primary Committee or the Secondary Committee shall be liable for any act or omission made in good faith with respect to the Plan or any option grants or stock
issuances under the Plan. 
  

 2. 

 F. Administration of the Automatic Option Grant and Director Fee Option Grant Programs shall be
self-executing in accordance with the terms of those programs, and no Plan Administrator shall exercise any discretionary functions with respect to any option grants or stock issuances made under those programs. 
  

	IV.	ELIGIBILITY 

 A. The persons eligible to
participate in the Discretionary Option Grant and Stock Issuance Programs are as follows: 
 (i) Employees, 
 (ii) non-employee members of the Board or the board of directors of any Parent or Subsidiary, and 
 (iii) consultants and other independent advisors who provide services to the Corporation (or any Parent or Subsidiary). 
 B. Only Employees who are Section 16 Insiders or other highly compensated individuals shall be eligible to participate in the Salary
Investment Option Grant Program. 
 C. Each Plan Administrator shall, within the scope of its administrative jurisdiction under the
Plan, have full authority to determine, (i) with respect to the option grants under the Discretionary Option Grant Program, which eligible persons are to receive such grants, the time or times when those grants are to be made, the number of
shares to be covered by each such grant, the status of the granted option as either an Incentive Option or a Non-Statutory Option, the time or times when each option is to become exercisable, the vesting schedule (if any) applicable to the option
shares and the maximum term for which the option is to remain outstanding and (ii) with respect to stock issuances under the Stock Issuance Program, which eligible persons are to receive such issuances, the time or times when the issuances are
to be made, the number of shares to be issued to each Participant, the vesting schedule (if any) applicable to the issued shares and the consideration for such shares. 
 D. The Plan Administrator shall have the absolute discretion either to grant options in accordance with the Discretionary Option Grant Program or to effect stock issuances in accordance with the Stock Issuance
Program. 
 E. The individuals who shall be eligible to participate in the Automatic Option Grant Program shall be limited to
(i) those individuals who first become non-employee Board members on or after the Underwriting Date, whether through appointment by the Board or election by the Corporation’s stockholders, and (ii) those individuals who continue to
serve as non-employee Board members at one or more Annual Stockholders Meetings held after the Underwriting Date. A non-employee Board member who has previously been in the employ of the Corporation (or any Parent or Subsidiary) shall not be
eligible to receive an option grant under the Automatic Option Grant Program at the time he or she first becomes a non-employee Board member, but shall be eligible to receive periodic option grants under the Automatic Option Grant Program while he
or she continues to serve as a non-employee Board member. 
  

 3. 

 F. All non-employee Board members shall be eligible to participate in the Director Fee Option
Grant Program. 
  

	V.	STOCK SUBJECT TO THE PLAN 

 A. The stock
issuable under the Plan shall be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Corporation on the open market. The number of shares of Common Stock initially reserved for issuance over the term of
the Plan shall not exceed 5,750,000 shares. Such reserve shall consist of (i) the number of shares estimated to remain available for issuance, as of the Plan Effective Date, under the Predecessor Plan as last approved by the Corporation’s
stockholders, including the shares subject to outstanding options under the Predecessor Plan, plus (ii) an additional increase of approximately 850,000 shares to be approved by the Corporation’s stockholders prior to the Underwriting Date,
plus (iii) 1,000,000 shares of Common Stock to be used for issuances to persons not previously an employee or director of the Corporation, or following a bona fide period of non-employment, as an inducement material to such persons entering
into employment with the Corporation (the “Inducement Shares”). 
 B. The number of shares of Common Stock available
for issuance under the Plan shall automatically increase on the first trading day of January each calendar year during the term of the Plan, beginning with calendar year 2001, by an amount equal to four percent (4%) of the total number of
shares of Common Stock outstanding on the last trading day in December of the immediately preceding calendar year, but in no event shall any such annual increase exceed 2,000,000 shares; provided, however, effective upon the approval of the
Corporation’s 2006 Equity Incentive Plan by the Corporation’s stockholders, the automatic increase in the number of shares available for issuance under the Plan as set forth in this Section shall cease, and this Section shall have no
further force or effect. 
 C. No one person participating in the Plan may receive stock options, separately exercisable stock
appreciation rights and direct stock issuances for more than 1,000,000 shares (excluding Inducement Shares) of Common Stock in the aggregate per calendar year. 
 D. Shares of Common Stock subject to outstanding options (including options incorporated into this Plan from the Predecessor Plan) shall be available for subsequent issuance under the Plan to the extent
(i) those options expire or terminate for any reason prior to exercise in full or (ii) the options are cancelled in accordance with the cancellation-regrant provisions of Article Two. Unvested shares issued under the Plan and subsequently
cancelled or repurchased by the Corporation at the original issue price paid per share, pursuant to the Corporation’s repurchase rights under the Plan shall be added back to the number of shares of Common Stock reserved for issuance under the
Plan and shall accordingly be available for reissuance through one or more subsequent option grants or direct stock issuances under the Plan. Notwithstanding the foregoing, Inducement Shares shall be available for subsequent issuance under the Plan
if, and only if, such subsequent issuance complies with Nasdaq Marketplace Rule 4350(i)(1)(A)(iv), or an applicable successor rule. However, should the exercise price of an option under the Plan be paid with shares of Common Stock or should shares
of Common Stock otherwise issuable under the Plan be withheld by the Corporation in satisfaction of the withholding taxes incurred in connection with the exercise of an option or the vesting of a stock issuance under the Plan, then 

  

 4. 

 
the number of shares of Common Stock available for issuance under the Plan shall be reduced by the gross number of shares for which the option is exercised
or which vest under the stock issuance, and not by the net number of shares of Common Stock issued to the holder of such option or stock issuance. Shares of Common Stock underlying one or more stock appreciation rights exercised under Section IV of
Article Two, Section III of Article Three, Section II of Article Five or Section III of Article Six of the Plan shall not be available for subsequent issuance under the Plan. 
 E. If any change is made to the Common Stock by reason of any stock split, stock dividend, recapitalization, combination of shares, exchange of
shares or other change affecting the outstanding Common Stock as a class without the Corporation’s receipt of consideration, appropriate adjustments shall be made by the Plan Administrator to (i) the maximum number and/or class of
securities issuable under the Plan, (ii) the maximum number and/or class of securities for which any one person may be granted stock options, separately exercisable stock appreciation rights and direct stock issuances under the Plan per
calendar year, (iii) the number and/or class of securities for which grants are subsequently to be made under the Automatic Option Grant Program to new and continuing non-employee Board members, (iv) the number and/or class of securities
and the exercise price per share in effect under each outstanding option under the Plan, (v) the number and/or class of securities and exercise price per share in effect under each outstanding option incorporated into this Plan from the
Predecessor Plan and (vi) the maximum number and/or class of securities by which the share reserve is to increase automatically each calendar year pursuant to the provisions of Section V.B of this Article One. Such adjustments to the
outstanding options are to be effected in a manner which shall preclude the enlargement or dilution of rights and benefits under such options. The adjustments determined by the Plan Administrator shall be final, binding and conclusive. 

ARTICLE TWO 
 DISCRETIONARY
OPTION GRANT PROGRAM 
  

	I.	OPTION TERMS 

 Each option shall be evidenced by one
or more documents in the form approved by the Plan Administrator; provided, however, that each such document shall comply with the terms specified below. Each document evidencing an Incentive Option shall, in addition, be subject to the provisions
of the Plan applicable to such options. 
 A. Exercise Price. 
 1. The exercise price per share shall be fixed by the Plan Administrator but shall not be less than one hundred percent (100%) of the Fair
Market Value per share of Common Stock on the option grant date. 
 2. The exercise price shall become immediately due upon exercise
of the option and shall, subject to the provisions of Section I of Article Seven and the documents evidencing the option, be payable in one or more of the forms specified below: 
 (i) cash or check made payable to the Corporation, 
  

 5. 

 (ii) shares of Common Stock held for the requisite period necessary to avoid a charge to the
Corporation’s earnings for financial reporting purposes and valued at Fair Market Value on the Exercise Date, or 
 (iii) to the
extent the option is exercised for vested shares, through a special sale and remittance procedure pursuant to which the Optionee shall concurrently provide irrevocable instructions to (a) a Corporation-designated brokerage firm to effect the
immediate sale of the purchased shares and remit to the Corporation, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate exercise price payable for the purchased shares plus all applicable Federal,
state and local income and employment taxes required to be withheld by the Corporation by reason of such exercise and (b) the Corporation to deliver the certificates for the purchased shares directly to such brokerage firm in order to complete
the sale. 
 Except to the extent such sale and remittance procedure is utilized, payment of the exercise price for the purchased shares must
be made on the Exercise Date. 
 B. Exercise and Term of Options. Each option shall be exercisable at such time or times, during such
period and for such number of shares as shall be determined by the Plan Administrator and set forth in the documents evidencing the option. However, no option shall have a term in excess of ten (10) years measured from the option grant date.

 C. Effect of Termination of Service. 
 1. The following provisions shall govern the exercise of any options held by the Optionee at the time of cessation of Service or death: 
 (i) Any option outstanding at the time of the Optionee’s cessation of Service for any reason shall remain exercisable for such period of time
thereafter as shall be determined by the Plan Administrator and set forth in the documents evidencing the option, but no such option shall be exercisable after the expiration of the option term. 
 (ii) Any option held by the Optionee at the time of death and exercisable in whole or in part at that time may be subsequently exercised by the
personal representative of the Optionee’s estate or by the person or persons to whom the option is transferred pursuant to the Optionee’s will or the laws of inheritance or by the Optionee’s designated beneficiary or beneficiaries of
that option. 
 (iii) Should the Optionee’s Service be terminated for Misconduct or should the Optionee otherwise engage in
Misconduct while holding one or more outstanding options under this Article Two, then all those options shall terminate immediately and cease to be outstanding. 
 (iv) During the applicable post-Service exercise period, the option may not be exercised in the aggregate for more than the number of vested shares for which the option is exercisable on the date of the
Optionee’s cessation of Service. Upon the expiration of the applicable exercise period or (if earlier) upon the expiration of the option term, the option shall terminate and cease to be outstanding for any vested shares for which the option has
not been 

  

 6. 

 
exercised. However, the option shall, immediately upon the Optionee’s cessation of Service, terminate and cease to be outstanding to the extent the
option is not otherwise at that time exercisable for vested shares. 
 2. The Plan Administrator shall have complete discretion,
exercisable either at the time an option is granted or at any time while the option remains outstanding, to: 
 (i) extend the period
of time for which the option is to remain exercisable following the Optionee’s cessation of Service from the limited exercise period otherwise in effect for that option to such greater period of time as the Plan Administrator shall deem
appropriate, but in no event beyond the expiration of the option term, and/or 
 (ii) permit the option to be exercised, during the
applicable post-Service exercise period, not only with respect to the number of vested shares of Common Stock for which such option is exercisable at the time of the Optionee’s cessation of Service but also with respect to one or more
additional installments in which the Optionee would have vested had the Optionee continued in Service. 
 D. Stockholder Rights. The
holder of an option shall have no stockholder rights with respect to the shares subject to the option until such person shall have exercised the option, paid the exercise price and become a holder of record of the purchased shares. 
 E. Repurchase Rights. The Plan Administrator shall have the discretion to grant options which are exercisable for unvested shares of Common Stock.
Should the Optionee cease Service while holding such unvested shares, the Corporation shall have the right to repurchase, at the exercise price paid per share, any or all of those unvested shares. The terms upon which such repurchase right shall be
exercisable (including the period and procedure for exercise and the appropriate vesting schedule for the purchased shares) shall be established by the Plan Administrator and set forth in the document evidencing such repurchase right. 
 F. Limited Transferability of Options. During the lifetime of the Optionee, Incentive Options shall be exercisable only by the Optionee and shall
not be assignable or transferable other than by will or the laws of inheritance following the Optionee’s death. Non-Statutory Options shall be subject to the same restriction, except that a Non-Statutory Option may be assigned in whole or in
part during the Optionee’s lifetime to one or more members of the Optionee’s family or to a trust established exclusively for one or more such family members or to Optionee’s former spouse, to the extent such assignment is in
connection with the Optionee’s estate plan or pursuant to a domestic relations order. The assigned portion may only be exercised by the person or persons who acquire a proprietary interest in the option pursuant to the assignment. The terms
applicable to the assigned portion shall be the same as those in effect for the option immediately prior to such assignment and shall be set forth in such documents issued to the assignee as the Plan Administrator may deem appropriate. 

Notwithstanding the foregoing, the Optionee may also designate one or more persons as the beneficiary or beneficiaries of his or her outstanding
options under this Article Two, and those options shall, in accordance with such designation, automatically be transferred to such beneficiary or beneficiaries upon the Optionee’s death while holding those options. Such 

  

 7. 

 
beneficiary or beneficiaries shall take the transferred options subject to all the terms and conditions of the applicable agreement evidencing each such
transferred option, including (without limitation) the limited time period during which the option may be exercised following the Optionee’s death. 
  

	II.	INCENTIVE OPTIONS 

 The terms specified below shall
be applicable to all Incentive Options. Except as modified by the provisions of this Section II, all the provisions of Articles One, Two and Seven shall be applicable to Incentive Options. Options which are specifically designated as Non-Statutory
Options when issued under the Plan shall not be subject to the terms of this Section II. 
 A. Eligibility. Incentive Options may only
be granted to Employees. 
 B. Dollar Limitation. The aggregate Fair Market Value of the shares of Common Stock (determined as of the
respective date or dates of grant) for which one or more options granted to any Employee under the Plan (or any other option plan of the Corporation or any Parent or Subsidiary) may for the first time become exercisable as Incentive Options during
any one calendar year shall not exceed the sum of One Hundred Thousand Dollars ($100,000). To the extent the Employee holds two (2) or more such options which become exercisable for the first time in the same calendar year, the foregoing
limitation on the exercisability of such options as Incentive Options shall be applied on the basis of the order in which such options are granted. 
 C. 10% Stockholder. If any Employee to whom an Incentive Option is granted is a 10% Stockholder, then the exercise price per share shall not be less than one hundred ten percent (110%) of the Fair Market Value per share of
Common Stock on the option grant date, and the option term shall not exceed five (5) years measured from the option grant date. 
  

	III.	CORPORATE TRANSACTION/CHANGE IN CONTROL 

 A.
In the event of any Corporate Transaction, each outstanding option shall automatically accelerate so that each such option shall, immediately prior to the effective date of the Corporate Transaction, become exercisable for all the shares of
Common Stock at the time subject to such option and may be exercised for any or all of those shares as fully vested shares of Common Stock. However, an outstanding option shall not become exercisable on such an accelerated basis if and to the
extent: (i) such option is, in connection with the Corporate Transaction, to be assumed by the successor corporation (or parent thereof) or (ii) such option is to be replaced with a cash incentive program of the successor corporation which
preserves the spread existing at the time of the Corporate Transaction on any shares for which the option is not otherwise at that time exercisable and provides for subsequent payout in accordance with the same exercise/vesting schedule applicable
to those option shares or (iii) the acceleration of such option is subject to other limitations imposed by the Plan Administrator at the time of the option grant. 
 B. All outstanding repurchase rights shall automatically terminate, and the shares of Common Stock subject to those terminated rights shall immediately vest in full, in the event of any Corporate Transaction,
except to the extent: (i) those repurchase rights are to be assigned to the successor corporation (or parent thereof) in connection with such Corporate Transaction or (ii) such accelerated vesting is precluded by other limitations imposed by
the Plan Administrator at the time the repurchase right is issued. 
  

 8. 

 C. Immediately following the consummation of the Corporate Transaction, all outstanding options
shall terminate and cease to be outstanding, except to the extent assumed by the successor corporation (or parent thereof). 
 D. Each
option which is assumed in connection with a Corporate Transaction shall be appropriately adjusted, immediately after such Corporate Transaction, to apply to the number and class of securities which would have been issuable to the Optionee in
consummation of such Corporate Transaction had the option been exercised immediately prior to such Corporate Transaction. Appropriate adjustments to reflect such Corporate Transaction shall also be made to (i) the exercise price payable per
share under each outstanding option, provided the aggregate exercise price payable for such securities shall remain the same, (ii) the maximum number and/or class of securities available for issuance over the remaining term of the Plan and
(iii) the maximum number and/or class of securities for which any one person may be granted stock options, separately exercisable stock appreciation rights and direct stock issuances under the Plan per calendar year and (iv) the maximum
number and/or class of securities by which the share reserve is to increase automatically each calendar year. To the extent the actual holders of the Corporation’s outstanding Common Stock receive cash consideration for their Common Stock in
consummation of the Corporate Transaction, the successor corporation may, in connection with the assumption of the outstanding options under the Discretionary Option Grant Program, substitute one or more shares of its own common stock with a fair
market value equivalent to the cash consideration paid per share of Common Stock in such Corporate Transaction. 
 E. The Plan
Administrator shall have the discretionary authority to structure one or more outstanding options under the Discretionary Option Grant Program so that those options shall, immediately prior to the effective date of such Corporate Transaction, become
exercisable for all the shares of Common Stock at the time subject to those options and may be exercised for any or all of those shares as fully vested shares of Common Stock, whether or not those options are to be assumed in the Corporate
Transaction. In addition, the Plan Administrator shall have the discretionary authority to structure one or more of the Corporation’s repurchase rights under the Discretionary Option Grant Program so that those rights shall not be assignable in
connection with such Corporate Transaction and shall accordingly terminate upon the consummation of such Corporate Transaction, and the shares subject to those terminated rights shall thereupon vest in full. 
 F. The Plan Administrator shall have full power and authority to structure one or more outstanding options under the Discretionary Option Grant
Program so that those options shall become exercisable for all the shares of Common Stock at the time subject to those options in the event the Optionee’s Service is subsequently terminated by reason of an Involuntary Termination within a
designated period (not to exceed eighteen (18) months) following the effective date of any Corporate Transaction in which those options are assumed and do not otherwise accelerate. In addition, the Plan Administrator may structure one or more
of the Corporation’s repurchase rights so that those rights shall immediately terminate with respect to any shares held by the Optionee at the time of his or her Involuntary Termination, and the shares subject to those terminated repurchase
rights shall accordingly vest in full at that time. 
  

 9. 

 G. The Plan Administrator shall have the discretionary authority to structure one or more
outstanding options under the Discretionary Option Grant Program so that those options shall, immediately prior to the effective date of a Change in Control, become exercisable for all the shares of Common Stock at the time subject to those options
and may be exercised for any or all of those shares as fully vested shares of Common Stock. In addition, the Plan Administrator shall have the discretionary authority to structure one or more of the Corporation’s repurchase rights under the
Discretionary Option Grant Program so that those rights shall terminate automatically upon the consummation of such Change in Control, and the shares subject to those terminated rights shall thereupon vest in full. Alternatively, the Plan
Administrator may condition the automatic acceleration of one or more outstanding options under the Discretionary Option Grant Program and the termination of one or more of the Corporation’s outstanding repurchase rights under such program upon
the subsequent termination of the Optionee’s Service by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of such Change in Control. 
 H. The portion of any Incentive Option accelerated in connection with a Corporate Transaction or Change in Control shall remain exercisable as an
Incentive Option only to the extent the applicable One Hundred Thousand Dollar ($100,000) limitation is not exceeded. To the extent such dollar limitation is exceeded, the accelerated portion of such option shall be exercisable as a Nonstatutory
Option under the Federal tax laws. 
 I. The outstanding options shall in no way affect the right of the Corporation to adjust,
reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets. 
  

	IV.	CANCELLATION AND REGRANT OF OPTIONS 

 The Plan
Administrator shall have the authority to effect, at any time and from time to time, with the consent of the affected option holders, the cancellation of any or all outstanding options under the Discretionary Option Grant Program (including
outstanding options incorporated from the Predecessor Plan) and to grant in substitution new options covering the same or a different number of shares of Common Stock but with an exercise price per share based on the Fair Market Value per share of
Common Stock on the new grant date. 
  

	V.	STOCK APPRECIATION RIGHTS 

 A. The Plan
Administrator shall have full power and authority to grant to selected Optionees tandem stock appreciation rights and/or limited stock appreciation rights. 
 B. The following terms shall govern the grant and exercise of tandem stock appreciation rights: 
 (i) One or more Optionees may be granted the right, exercisable upon such terms as the Plan Administrator may establish, to elect between the exercise of the underlying option for shares of Common Stock and the surrender of that
option in exchange for a distribution from the Corporation in an amount equal to the excess of (a) the Fair Market Value (on the option surrender date) of the number of shares in which the Optionee is at the time vested under the surrendered
option (or surrendered portion thereof) over (b) the aggregate exercise price payable for such shares. 
  

 10. 

 (ii) No such option surrender shall be effective unless it is approved by the Plan Administrator,
either at the time of the actual option surrender or at any earlier time. If the surrender is so approved, then the distribution to which the Optionee shall be entitled may be made in shares of Common Stock valued at Fair Market Value on the option
surrender date, in cash, or partly in shares and partly in cash, as the Plan Administrator shall in its sole discretion deem appropriate. 
 (iii) If the surrender of an option is not approved by the Plan Administrator, then the Optionee shall retain whatever rights the Optionee had under the surrendered option (or surrendered portion thereof) on the option surrender date
and may exercise such rights at any time prior to the later of (a) five (5) business days after the receipt of the rejection notice or (b) the last day on which the option is otherwise exercisable in accordance with the terms of the
documents evidencing such option, but in no event may such rights be exercised more than ten (10) years after the option grant date. 
 C. The following terms shall govern the grant and exercise of limited stock appreciation rights: 
 (i) One or more
Section 16 Insiders may be granted limited stock appreciation rights with respect to their outstanding options. 
 (ii) Upon the
occurrence of a Hostile Take-Over, each individual holding one or more options with such a limited stock appreciation right shall have the unconditional right (exercisable for a thirty (30)-day period following such Hostile Take-Over) to surrender
each such option to the Corporation. In return for the surrendered option, the Optionee shall receive a cash distribution from the Corporation in an amount equal to the excess of (A) the Take-Over Price of the shares of Common Stock at the time
subject to such option (whether or not the option is otherwise at that time exercisable for those shares) over (B) the aggregate exercise price payable for those shares. Such cash distribution shall be paid within five (5) days following
the option surrender date. 
 (iii) At the time such limited stock appreciation right is granted, the Plan Administrator shall
pre-approve any subsequent exercise of that right in accordance with the terms of this Paragraph C. Accordingly, no further approval of the Plan Administrator or the Board shall be required at the time of the actual option surrender and cash
distribution. 
 ARTICLE THREE 
 SALARY INVESTMENT OPTION GRANT PROGRAM 
  

	I.	OPTION GRANTS 

 The Primary Committee shall have the
sole and exclusive authority to determine the calendar year or years (if any) for which the Salary Investment Option Grant Program is to be in effect and to select the Section 16 Insiders and other highly compensated Employees eligible to

  

 11. 

 
participate in the Salary Investment Option Grant Program for such calendar year or years. Each selected individual who elects to participate in the Salary
Investment Option Grant Program must, prior to the start of each calendar year of participation, file with the Plan Administrator (or its designate) an irrevocable authorization directing the Corporation to reduce his or her base salary for that
calendar year by an amount not less than Ten Thousand Dollars ($10,000.00) nor more than Fifty Thousand Dollars ($50,000.00). Each individual who files such a timely authorization shall automatically be granted an option under the Salary Investment
Grant Program on the first trading day in January of the calendar year for which the salary reduction is to be in effect. 
  

	II.	OPTION TERMS 

 Each option shall be a Non-Statutory
Option evidenced by one or more documents in the form approved by the Plan Administrator; provided, however, that each such document shall comply with the terms specified below. 
 A. Exercise Price. 
 1. The
exercise price per share shall be thirty-three and one-third percent (33-1/3%) of the Fair Market Value per share of Common Stock on the option grant date. 
 2. The exercise price shall become immediately due upon exercise of the option and shall be payable in one or more of the alternative forms authorized under the Discretionary Option Grant Program. Except to the
extent the sale and remittance procedure specified thereunder is utilized, payment of the exercise price for the purchased shares must be made on the Exercise Date. 
 B. Number of Option Shares. The number of shares of Common Stock subject to the option shall be determined pursuant to the following formula (rounded down to the nearest whole number): 
 X = A / (B x 66-2/3%), where 
 X is the number
of option shares, 
 A is the dollar amount of the reduction in the Optionee’s base salary for the calendar year to be in effect pursuant
to this program, and 
 B is the Fair Market Value per share of Common Stock on the option grant date. 
 C. Exercise and Term of Options. The option shall become exercisable in a series of twelve (12) successive equal monthly installments upon
the Optionee’s completion of each calendar month of Service in the calendar year for which the salary reduction is in effect. Each option shall have a maximum term of ten (10) years measured from the option grant date. 
 D. Effect of Termination of Service. Should the Optionee cease Service for any reason while holding one or more options under this Article Three,
then each such option shall remain exercisable, for any or all of the shares for which the option is exercisable at the time of 

  

 12. 

 
such cessation of Service, until the earlier of (i) the expiration of the ten (10)-year option term or (ii) the expiration of the three (3)-year
period measured from the date of such cessation of Service. Should the Optionee die while holding one or more options under this Article Three, then each such option may be exercised, for any or all of the shares for which the option is exercisable
at the time of the Optionee’s cessation of Service (less any shares subsequently purchased by Optionee prior to death), by the personal representative of the Optionee’s estate or by the person or persons to whom the option is transferred
pursuant to the Optionee’s will or the laws of inheritance or by the designated beneficiary or beneficiaries of the option. Such right of exercise shall lapse, and the option shall terminate, upon the earlier of (i) the expiration of the
ten (10)-year option term or (ii) the three (3)-year period measured from the date of the Optionee’s cessation of Service. However, the option shall, immediately upon the Optionee’s cessation of Service for any reason, terminate and
cease to remain outstanding with respect to any and all shares of Common Stock for which the option is not otherwise at that time exercisable. 
  

	III.	CORPORATE TRANSACTION/CHANGE IN CONTROL/HOSTILE TAKE-OVER 

 A. In the event of any Corporate Transaction while the Optionee remains in Service, each outstanding option held by such Optionee under this Salary Investment Option Grant Program shall automatically accelerate so that each such
option shall, immediately prior to the effective date of the Corporate Transaction, become exercisable for all the shares of Common Stock at the time subject to such option and may be exercised for any or all of those shares as fully vested shares
of Common Stock. Each such outstanding option shall terminate immediately following the Corporate Transaction, except to the extent assumed by the successor corporation (or parent thereof) in such Corporate Transaction. Any option so assumed and
shall remain exercisable for the fully vested shares until the earlier of (i) the expiration of the ten (10)-year option term or (ii) the expiration of the three (3)-year period measured from the date of the Optionee’s cessation of
Service. 
 B. In the event of a Change in Control while the Optionee remains in Service, each outstanding option held by such
Optionee under this Salary Investment Option Grant Program shall automatically accelerate so that each such option shall, immediately prior to the effective date of the Change in Control, become exercisable for all the shares of Common Stock at the
time subject to such option and may be exercised for any or all of those shares as fully vested shares of Common Stock. The option shall remain so exercisable until the earliest to occur of (i) the expiration of the ten (10)-year option term,
(ii) the expiration of the three (3)-year period measured from the date of the Optionee’s cessation of Service, (iii) the termination of the option in connection with a Corporate Transaction or (iv) the surrender of the option in
connection with a Hostile Take-Over. 
 C. Upon the occurrence of a Hostile Take-Over, the Optionee shall have a thirty (30)-day
period in which to surrender to the Corporation each outstanding option granted him or her under the Salary Investment Option Grant Program. The Optionee shall in return be entitled to a cash distribution from the Corporation in an amount equal to
the excess of (i) the Take-Over Price of the shares of Common Stock at the time subject to the surrendered option (whether or not the option is otherwise at the time exercisable for those shares) over (ii) the aggregate exercise price
payable for such shares. Such cash distribution shall be paid within five (5) days 

  

 13. 

 
following the surrender of the option to the Corporation. The Primary Committee shall, at the time the option with such limited stock appreciation right is
granted under the Salary Investment Option Grant Program, pre-approve any subsequent exercise of that right in accordance with the terms of this Paragraph C. Accordingly, no further approval of the Primary Committee or the Board shall be required at
the time of the actual option surrender and cash distribution. 
 D. Each option which is assumed in connection with a Corporate
Transaction shall be appropriately adjusted, immediately after such Corporate Transaction, to apply to the number and class of securities which would have been issuable to the Optionee in consummation of such Corporate Transaction had the option
been exercised immediately prior to such Corporate Transaction. Appropriate adjustments shall also be made to the exercise price payable per share under each outstanding option, provided the aggregate exercise price payable for such securities shall
remain the same. To the extent the actual holders of the Corporation’s outstanding Common Stock receive cash consideration for their Common Stock in consummation of the Corporate Transaction, the successor corporation may, in connection with
the assumption of the outstanding options under the Salary Investment Option Grant Program, substitute one or more shares of its own common stock with a fair market value equivalent to the cash consideration paid per share of Common Stock in such
Corporate Transaction. 
 E. The grant of options under the Salary Investment Option Grant Program shall in no way affect the right of
the Corporation to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets. 
  

	IV.	REMAINING TERMS 

 The remaining terms of each option
granted under the Salary Investment Option Grant Program shall be the same as the terms in effect for option grants made under the Discretionary Option Grant Program. 
 ARTICLE FOUR 
 STOCK ISSUANCE PROGRAM 
  

	I.	STOCK ISSUANCE TERMS 

 Shares of Common Stock may be
issued under the Stock Issuance Program through direct and immediate issuances without any intervening option grants. Each such stock issuance shall be evidenced by a Stock Issuance Agreement which complies with the terms specified below. Shares of
Common Stock may also be issued under the Stock Issuance Program pursuant to share right awards which entitle the recipients to receive those shares upon the attainment of designated performance goals. 
 A. Purchase Price. 
 1. The
purchase price per share shall be fixed by the Plan Administrator, but shall not be less than one hundred percent (100%) of the Fair Market Value per share of Common Stock on the issuance date. 
  

 14. 

 2. Subject to the provisions of Section I of Article Seven, shares of Common Stock may be issued
under the Stock Issuance Program for any of the following items of consideration which the Plan Administrator may deem appropriate in each individual instance: 
 (i) cash or check made payable to the Corporation, or 
 (ii) past services rendered to the
Corporation (or any Parent or Subsidiary). 
  

	B.	Vesting Provisions. 

 1. Shares of Common
Stock issued under the Stock Issuance Program may, in the discretion of the Plan Administrator, be fully and immediately vested upon issuance or may vest in one or more installments over the Participant’s period of Service or upon attainment of
specified performance objectives. The elements of the vesting schedule applicable to any unvested shares of Common Stock issued under the Stock Issuance Program shall be determined by the Plan Administrator and incorporated into the Stock Issuance
Agreement. Shares of Common Stock may also be issued under the Stock Issuance Program pursuant to share right awards which entitle the recipients to receive those shares upon the attainment of designated performance goals. 
 2. Any new, substituted or additional securities or other property (including money paid other than as a regular cash dividend) which the
Participant may have the right to receive with respect to the Participant’s unvested shares of Common Stock by reason of any stock dividend, stock split, recapitalization, combination of shares, exchange of shares or other change affecting the
outstanding Common Stock as a class without the Corporation’s receipt of consideration shall be issued subject to (i) the same vesting requirements applicable to the Participant’s unvested shares of Common Stock and (ii) such
escrow arrangements as the Plan Administrator shall deem appropriate. 
 3. The Participant shall have full stockholder rights with
respect to any shares of Common Stock issued to the Participant under the Stock Issuance Program, whether or not the Participant’s interest in those shares is vested. Accordingly, the Participant shall have the right to vote such shares and to
receive any regular cash dividends paid on such shares. 
 4. Should the Participant cease to remain in Service while holding one or
more unvested shares of Common Stock issued under the Stock Issuance Program or should the performance objectives not be attained with respect to one or more such unvested shares of Common Stock, then those shares shall be immediately surrendered to
the Corporation for cancellation, and the Participant shall have no further stockholder rights with respect to those shares. To the extent the surrendered shares were previously issued to the Participant for consideration paid in cash or cash
equivalent (including the Participant’s purchase-money indebtedness), the Corporation shall repay to the Participant the cash consideration paid for the surrendered shares and shall cancel the unpaid principal balance of any outstanding
purchase-money note of the Participant attributable to the surrendered shares. 
 5. The Plan Administrator may in its discretion
waive the surrender and cancellation of one or more unvested shares of Common Stock which would otherwise occur 

  

 15. 

 
upon the cessation of the Participant’s Service or the non-attainment of the performance objectives applicable to those shares. Such waiver shall result
in the immediate vesting of the Participant’s interest in the shares of Common Stock as to which the waiver applies. Such waiver may be effected at any time, whether before or after the Participant’s cessation of Service or the attainment
or non-attainment of the applicable performance objectives. 
 6. Outstanding share right awards under the Stock Issuance Program
shall automatically terminate, and no shares of Common Stock shall actually be issued in satisfaction of those awards, if the performance goals established for such awards are not attained. The Plan Administrator, however, shall have the
discretionary authority to issue shares of Common Stock under one or more outstanding share right awards as to which the designated performance goals have not been attained. 
  

	II.	CORPORATE TRANSACTION/CHANGE IN CONTROL 

 A.
All of the Corporation’s outstanding repurchase rights under the Stock Issuance Program shall terminate automatically, and all the shares of Common Stock subject to those terminated rights shall immediately vest in full, in the event of any
Corporate Transaction, except to the extent (i) those repurchase rights are to be assigned to the successor corporation (or parent thereof) in connection with such Corporate Transaction or (ii) such accelerated vesting is precluded by
other limitations imposed in the Stock Issuance Agreement. 
 B. The Plan Administrator shall have the discretionary authority to
structure one or more of the Corporation’s repurchase rights under the Stock Issuance Program so that those rights shall automatically terminate in whole or in part, and the shares of Common Stock subject to those terminated rights shall
immediately vest, in the event the Participant’s Service should subsequently terminate by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of any Corporate
Transaction in which those repurchase rights are assigned to the successor corporation (or parent thereof). 
 C. The Plan
Administrator shall also have the discretionary authority to structure one or more of the Corporation’s repurchase rights under the Stock Issuance Program so that those rights shall automatically terminate in whole or in part, and the shares of
Common Stock subject to those terminated rights shall immediately vest, in the event the Participant’s Service should subsequently terminate by reason of an Involuntary Termination within a designated period (not to exceed eighteen
(18) months) following the effective date of any Change in Control. 
  

	III.	SHARE ESCROW/LEGENDS 

 Unvested shares may, in the
Plan Administrator’s discretion, be held in escrow by the Corporation until the Participant’s interest in such shares vests or may be issued directly to the Participant with restrictive legends on the certificates evidencing those unvested
shares. 
  

 16. 

 ARTICLE FIVE 
 AUTOMATIC OPTION GRANT PROGRAM 
  

	I.	OPTION TERMS 

 A. Grant Dates. Option grants
shall be made on the dates specified below: 
 1. Each individual who is first elected or appointed as a non-employee Board member at
any time on or after the Underwriting Date shall automatically be granted, on the date of such initial election or appointment, a Non-Statutory Option to purchase 15,000 shares of Common Stock, provided that individual has not previously been in the
employ of the Corporation or any Parent or Subsidiary. 
 2. On the date of each Annual Stockholders Meeting held after the
Underwriting Date, each individual who is to continue to serve as a non-employee Board member, whether or not that individual is standing for re-election to the Board at that particular Annual Meeting, shall automatically be granted a Non-Statutory
Option to purchase 15,000 shares of Common Stock, provided such individual has served as a non-employee Board member for at least six (6) months. There shall be no limit on the number of such 15,000-share option grants any one non-employee
Board member may receive over his or her period of Board service, and non-employee Board members who have previously been in the employ of the Corporation (or any Parent or Subsidiary) or who have otherwise received one or more stock option grants
from the Corporation prior to the Underwriting Date shall be eligible to receive one or more such annual option grants over their period of continued Board service. 
 B. Exercise Price. 
 1. The exercise price per share shall be equal to one hundred percent
(100%) of the Fair Market Value per share of Common Stock on the option grant date. 
 2. The exercise price shall be payable in
one or more of the alternative forms authorized under the Discretionary Option Grant Program. Except to the extent the sale and remittance procedure specified thereunder is utilized, payment of the exercise price for the purchased shares must be
made on the Exercise Date. 
 C. Option Term. Each option shall have a term of ten (10) years measured from the option grant
date. 
 D. Exercise and Vesting of Options. Each option shall be immediately exercisable for any or all of the option shares.
However, any unvested shares purchased under the option shall be subject to repurchase by the Corporation, at the exercise price paid per share, upon the Optionee’s cessation of Board service prior to vesting in those shares. The shares subject
to each initial 15,000-share grant shall vest, and the Corporation’s repurchase right shall lapse, in a series of three (3) successive equal annual installments upon the Optionee’s completion of each year of service as a Board member
over the three (3)-year period measured from the option grant date. The shares subject to each annual 3,000-share option grant shall vest in one installment upon the Optionee’s completion of the one (1)-year period of service measured from the
grant date. 
  

 17. 

 E. Limited Transferability of Options. Each option under this Article Five may be assigned in
whole or in part during the Optionee’s lifetime to one or more members of the Optionee’s family or to a trust established exclusively for one or more such family members or to Optionee’s former spouse, to the extent such assignment is
in connection with the Optionee’s estate plan or pursuant to domestic relations order. The assigned portion may only be exercised by the person or persons who acquire a proprietary interest in the option pursuant to the assignment. The terms
applicable to the assigned portion shall be the same as those in effect for the option immediately prior to such assignment and shall be set forth in such documents issued to the assignee as the Plan Administrator may deem appropriate. The Optionee
may also designate one or more persons as the beneficiary or beneficiaries of his or her outstanding options under this Article Five, and those options shall, in accordance with such designation, automatically be transferred to such beneficiary or
beneficiaries upon the Optionee’s death while holding those options. Such beneficiary or beneficiaries shall take the transferred options subject to all the terms and conditions of the applicable agreement evidencing each such transferred
option, including (without limitation) the limited time period during which the option may be exercised following the Optionee’s death. 
 F. Termination of Board Service. The following provisions shall govern the exercise of any options held by the Optionee at the time the Optionee ceases to serve as a Board member: 
 (i) The Optionee (or, in the event of Optionee’s death, the personal representative of the Optionee’s estate or the person or persons to
whom the option is transferred pursuant to the Optionee’s will or the laws of inheritance or the designated beneficiary or beneficiaries of such option) shall have a twelve (12)-month period following the date of such cessation of Board service
in which to exercise each such option. 
 (ii) During the twelve (12)-month exercise period, the option may not be exercised in the
aggregate for more than the number of vested shares of Common Stock for which the option is exercisable at the time of the Optionee’s cessation of Board service. 
 (iii) Should the Optionee cease to serve as a Board member by reason of death or Permanent Disability, then all shares at the time subject to the option shall immediately vest so that such option may, during
the twelve (12)-month exercise period following such cessation of Board service, be exercised for all or any portion of those shares as fully vested shares of Common Stock. 
 (iv) In no event shall the option remain exercisable after the expiration of the option term. Upon the expiration of the twelve (12)-month
exercise period or (if earlier) upon the expiration of the option term, the option shall terminate and cease to be outstanding for any vested shares for which the option has not been exercised. However, the option shall, immediately upon the
Optionee’s cessation of Board service for any reason other than death or Permanent Disability, terminate and cease to be outstanding to the extent the option is not otherwise at that time exercisable for vested shares. 
  

 18. 

	II.	CORPORATE TRANSACTION/CHANGE IN CONTROL/HOSTILE TAKE-OVER 

 A. In the event of any Corporate Transaction while the Optionee remains a Board member, the shares of Common Stock at the time subject to each outstanding option but not otherwise vested shall automatically vest in full so that each
such option shall, immediately prior to the effective date of the Corporate Transaction, become exercisable for all the option shares as fully vested shares of Common Stock and may be exercised for any or all of those vested shares. Immediately
following the consummation of the Corporate Transaction, each automatic option grant shall terminate and cease to be outstanding, except to the extent assumed by the successor corporation (or parent thereof). 
 B. In connection with any Change in Control while the Optionee remains a Board member, the shares of Common Stock at the time subject to each
outstanding option but not otherwise vested shall automatically vest in full so that each such option shall, immediately prior to the effective date of the Change in Control, become exercisable for all the option shares as fully vested shares of
Common Stock and may be exercised for any or all of those vested shares. Each such option shall remain exercisable for such fully vested option shares until the expiration or sooner termination of the option term or the surrender of the option in
connection with a Hostile Take-Over. 
 C. All outstanding repurchase rights under this Article Five shall automatically terminate,
and the shares of Common Stock subject to those terminated rights shall immediately vest in full, in the event of any Corporate Transaction or Change in Control. 
 D. Upon the occurrence of a Hostile Take-Over, the Optionee shall have a thirty (30)-day period in which to surrender to the Corporation each of his or her outstanding automatic option grants. The Optionee
shall in return be entitled to a cash distribution from the Corporation in an amount equal to the excess of (i) the Take-Over Price of the shares of Common Stock at the time subject to each surrendered option (whether or not the Optionee is
otherwise at the time vested in those shares) over (ii) the aggregate exercise price payable for such shares. Such cash distribution shall be paid within five (5) days following the surrender of the option to the Corporation. No approval
or consent of the Board or any Plan Administrator shall be required at the time of the actual option surrender and cash distribution. 
 E. Each option which is assumed in connection with a Corporate Transaction shall be appropriately adjusted, immediately after such Corporate Transaction, to apply to the number and class of securities which would have been issuable
to the Optionee in consummation of such Corporate Transaction had the option been exercised immediately prior to such Corporate Transaction. Appropriate adjustments shall also be made to the exercise price payable per share under each outstanding
option, provided the aggregate exercise price payable for such securities shall remain the same. To the extent the actual holders of the Corporation’s outstanding Common Stock receive cash consideration for their Common Stock in consummation of
the Corporate Transaction, the successor corporation may, in connection with the assumption of the outstanding options under the Automatic Option Grant Program, substitute one or more shares of its own common stock with a fair market value
equivalent to the cash consideration paid per share of Common Stock in such Corporate Transaction. 
  

 19. 

 F. The grant of options under the Automatic Option Grant Program shall in no way affect the right
of the Corporation to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets. 
  

	III.	REMAINING TERMS 

 The remaining terms of each option
granted under the Automatic Option Grant Program shall be the same as the terms in effect for option grants made under the Discretionary Option Grant Program. 
 ARTICLE SIX 
 DIRECTOR FEE OPTION GRANT PROGRAM 
  

	I.	OPTION GRANTS 

 The Primary Committee shall have the
sole and exclusive authority to determine the calendar year or years for which the Director Fee Option Grant Program is to be in effect. For each such calendar year the program is in effect, each non-employee Board member may irrevocably elect to
apply all or any portion of the annual retainer fee otherwise payable in cash for his or her service on the Board for that year to the acquisition of a special option grant under this Director Fee Option Grant Program. Such election must be filed
with the Corporation’s Chief Financial Officer prior to the first day of the calendar year for which the annual retainer fee which is the subject of that election is otherwise payable. Each non-employee Board member who files such a timely
election shall automatically be granted an option under this Director Fee Option Grant Program on the first trading day in January in the calendar year for which the annual retainer fee which is the subject of that election would otherwise be
payable in cash. 
  

	II.	OPTION TERMS 

 Each option shall be a Non-Statutory
Option governed by the terms and conditions specified below. 
 A. Exercise Price. 
 1. The exercise price per share shall be thirty-three and one-third percent (33-1/3%) of the Fair Market Value per share of Common Stock on the
option grant date. 
 2. The exercise price shall become immediately due upon exercise of the option and shall be payable in one or
more of the alternative forms authorized under the Discretionary Option Grant Program. Except to the extent the sale and remittance procedure specified thereunder is utilized, payment of the exercise price for the purchased shares must be made on
the Exercise Date. 
  

 20. 

 B. Number of Option Shares. The number of shares of Common Stock subject to the option shall be
determined pursuant to the following formula (rounded down to the nearest whole number): 
 X = A / (B x 66-2/3%), where 
 X is the number of option shares, 
 A is the
portion of the annual retainer fee subject to the non-employee Board member’s election, and 
 B is the Fair Market Value per share of
Common Stock on the option grant date. 
 C. Exercise and Term of Options. The option shall become exercisable in a series of twelve
(12) equal monthly installments upon the Optionee’s completion of each calendar month of Board service during the calendar year for which the retainer fee election is in effect. Each option shall have a maximum term of ten (10) years
measured from the option grant date. 
 D. Limited Transferability of Options. Each option under this Article Six may be assigned in
whole or in part during the Optionee’s lifetime to one or more members of the Optionee’s family or to a trust established exclusively for one or more such family members or to Optionee’s former spouse, to the extent such assignment is
in connection with Optionee’s estate plan or pursuant to a domestic relations order. The assigned portion may only be exercised by the person or persons who acquire a proprietary interest in the option pursuant to the assignment. The terms
applicable to the assigned portion shall be the same as those in effect for the option immediately prior to such assignment and shall be set forth in such documents issued to the assignee as the Plan Administrator may deem appropriate. The Optionee
may also designate one or more persons as the beneficiary or beneficiaries of his or her outstanding options under this Article Six, and those options shall, in accordance with such designation, automatically be transferred to such beneficiary or
beneficiaries upon the Optionee’s death while holding those options. Such beneficiary or beneficiaries shall take the transferred options subject to all the terms and conditions of the applicable agreement evidencing each such transferred
option, including (without limitation) the limited time period during which the option may be exercised following the Optionee’s death. 
 E. Termination of Board Service. Should the Optionee cease Board service for any reason (other than death or Permanent Disability) while holding one or more options under this Director Fee Option Grant Program, then each such option
shall remain exercisable, for any or all of the shares for which the option is exercisable at the time of such cessation of Board service, until the earlier of (i) the expiration of the ten (10)-year option term or (ii) the expiration of
the three (3)-year period measured from the date of such cessation of Board service. However, each option held by the Optionee under this Director Fee Option Grant Program at the time of his or her cessation of Board service shall immediately
terminate and cease to remain outstanding with respect to any and all shares of Common Stock for which the option is not otherwise at that time exercisable. 
 F. Death or Permanent Disability. Should the Optionee’s service as a Board member cease by reason of death or Permanent Disability, then each option held by such 

  

 21. 

 
Optionee under this Director Fee Option Grant Program shall immediately become exercisable for all the shares of Common Stock at the time subject to that
option, and the option may be exercised for any or all of those shares as fully vested shares until the earlier of (i) the expiration of the ten (10)-year option term or (ii) the expiration of the three (3)-year period measured from the
date of such cessation of Board service. In the event of the Optionee’s death while holding such option, the option may be exercised by the personal representative of the Optionee’s estate or by the person or persons to whom the option is
transferred pursuant to the Optionee’s will or the laws of inheritance or by the designated beneficiary or beneficiaries of such option. 
 Should the Optionee die after cessation of Board service but while holding one or more options under this Director Fee Option Grant Program, then each such option may be exercised, for any or all of the shares for which the option is
exercisable at the time of the Optionee’s cessation of Board service (less any shares subsequently purchased by Optionee prior to death), by the personal representative of the Optionee’s estate or by the person or persons to whom the
option is transferred pursuant to the Optionee’s will or the laws of inheritance or by the designated beneficiary or beneficiaries of such option. 
 Such right of exercise shall lapse, and the option shall terminate, upon the earlier of (i) the expiration of the ten (10)-year option term or (ii) the three (3)-year period measured from the date of the
Optionee’s cessation of Board service. 
  

	III.	CORPORATE TRANSACTION/CHANGE IN CONTROL/HOSTILE TAKE-OVER 

 A. In the event of any Corporate Transaction while the Optionee remains a Board member, each outstanding option held by such Optionee under this Director Fee Option Grant Program shall automatically accelerate so that each such
option shall, immediately prior to the effective date of the Corporate Transaction, become exercisable for all the shares of Common Stock at the time subject to such option and may be exercised for any or all of those shares as fully vested shares
of Common Stock. Each such outstanding option shall terminate immediately following the Corporate Transaction, except to the extent assumed by the successor corporation (or parent thereof) in such Corporate Transaction. Any option so assumed and
shall remain exercisable for the fully vested shares until the earlier of (i) the expiration of the ten (10)-year option term or (ii) the expiration of the three (3)-year period measured from the date of the Optionee’s cessation of
Board service. 
 B. In the event of a Change in Control while the Optionee remains in Service, each outstanding option held by such
Optionee under this Director Fee Option Grant Program shall automatically accelerate so that each such option shall, immediately prior to the effective date of the Change in Control, become exercisable for all the shares of Common Stock at the time
subject to such option and may be exercised for any or all of those shares as fully vested shares of Common Stock. The option shall remain so exercisable until the earliest to occur of (i) the expiration of the ten (10)-year option term,
(ii) the expiration of the three (3)-year period measured from the date of the Optionee’s cessation of Board service, (iii) the termination of the option in connection with a Corporate Transaction or (iv) the surrender of the
option in connection with a Hostile Take-Over. 
  

 22. 

 C. Upon the occurrence of a Hostile Take-Over, the Optionee shall have a thirty (30)-day period in
which to surrender to the Corporation each outstanding option granted him or her under the Director Fee Option Grant Program. The Optionee shall in return be entitled to a cash distribution from the Corporation in an amount equal to the excess of
(i) the Take-Over Price of the shares of Common Stock at the time subject to each surrendered option (whether or not the option is otherwise at the time exercisable for those shares) over (ii) the aggregate exercise price payable for such
shares. Such cash distribution shall be paid within five (5) days following the surrender of the option to the Corporation. No approval or consent of the Board or any Plan Administrator shall be required at the time of the actual option
surrender and cash distribution. 
 D. Each option which is assumed in connection with a Corporate Transaction shall be appropriately
adjusted, immediately after such Corporate Transaction, to apply to the number and class of securities which would have been issuable to the Optionee in consummation of such Corporate Transaction had the option been exercised immediately prior to
such Corporate Transaction. Appropriate adjustments shall also be made to the exercise price payable per share under each outstanding option, provided the aggregate exercise price payable for such securities shall remain the same. To the extent the
actual holders of the Corporation’s outstanding Common Stock receive cash consideration for their Common Stock in consummation of the Corporate Transaction, the successor corporation may, in connection with the assumption of the outstanding
options under the Director Fee Option Grant Program, substitute one or more shares of its own common stock with a fair market value equivalent to the cash consideration paid per share of Common Stock in such Corporate Transaction. 
 E. The grant of options under the Director Fee Option Grant Program shall in no way affect the right of the Corporation to adjust, reclassify,
reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets. 
  

	IV.	REMAINING TERMS 

 The remaining terms of each option
granted under this Director Fee Option Grant Program shall be the same as the terms in effect for option grants made under the Discretionary Option Grant Program. 
 ARTICLE SEVEN 
 MISCELLANEOUS 
  

	I.	FINANCING 

 The Plan Administrator may permit any
Optionee or Participant to pay the option exercise price under the Discretionary Option Grant Program or the purchase price of shares issued under the Stock Issuance Program by delivering a full-recourse, interest-bearing promissory note payable in
one or more installments. The terms of any such promissory note (including the interest rate and the terms of repayment) shall be established by the Plan Administrator in its sole discretion. In no event may the maximum credit available to the
Optionee or Participant exceed the sum of (i) the aggregate option exercise price or purchase 

  

 23. 

 
price payable for the purchased shares (less the par value of such shares) plus (ii) any Federal, state and local income and employment tax liability
incurred by the Optionee or the Participant in connection with the option exercise or share purchase. 
  

	II.	TAX WITHHOLDING 

 A. The Corporation’s
obligation to deliver shares of Common Stock upon the exercise of options or the issuance or vesting of such shares under the Plan shall be subject to the satisfaction of all applicable Federal, state and local income and employment tax withholding
requirements. 
 B. The Plan Administrator may, in its discretion, provide any or all holders of Non-Statutory Options or unvested
shares of Common Stock under the Plan (other than the options granted or the shares issued under the Automatic Option Grant or Director Fee Option Grant Program) with the right to use shares of Common Stock in satisfaction of all or part of the
Withholding Taxes to which such holders may become subject in connection with the exercise of their options or the vesting of their shares. Such right may be provided to any such holder in either or both of the following formats: 
 Stock Withholding: The election to have the Corporation withhold, from the shares of Common Stock otherwise issuable upon the exercise of such
Non-Statutory Option or the vesting of such shares, a portion of those shares with an aggregate Fair Market Value equal to the percentage of the Withholding Taxes (not to exceed one hundred percent (100%)) designated by the holder. 

Stock Delivery: The election to deliver to the Corporation, at the time the Non-Statutory Option is exercised or the shares vest, one or more
shares of Common Stock previously acquired by such holder (other than in connection with the option exercise or share vesting triggering the Withholding Taxes) with an aggregate Fair Market Value equal to the percentage of the Withholding Taxes (not
to exceed one hundred percent (100%)) designated by the holder. 
  

	III.	EFFECTIVE DATE AND TERM OF THE PLAN 

 A. The
Plan shall become effective immediately on the Plan Effective Date. However, the Salary Investment Option Grant Program and the Director Fee Option Grant Program shall not be implemented until such time as the Primary Committee may deem appropriate.
Options may be granted under the Discretionary Option Grant at any time on or after the Plan Effective Date, and the initial option grants under the Automatic Option Grant Program shall also be made on the Plan Effective Date to any non-employee
Board members eligible for such grants at that time. However, no options granted under the Plan may be exercised, and no shares shall be issued under the Plan, until the Plan is approved by the Corporation’s stockholders. If such stockholder
approval is not obtained within twelve (12) months after the Plan Effective Date, then all options previously granted under this Plan shall terminate and cease to be outstanding, and no further options shall be granted and no shares shall be
issued under the Plan. 
 B. The Plan shall serve as the successor to the Predecessor Plan, and no further option grants or direct
stock issuances shall be made under the Predecessor Plan after the Plan 

  

 24. 

 
Effective Date. All options outstanding under the Predecessor Plan on the Plan Effective Date shall be incorporated into the Plan at that time and shall be
treated as outstanding options under the Plan. However, each outstanding option so incorporated shall continue to be governed solely by the terms of the documents evidencing such option, and no provision of the Plan shall be deemed to affect or
otherwise modify the rights or obligations of the holders of such incorporated options with respect to their acquisition of shares of Common Stock. 
 C. One or more provisions of the Plan, including (without limitation) the option/vesting acceleration provisions of Article Two relating to Corporate Transactions and Changes in Control, may, in the Plan Administrator’s
discretion, be extended to one or more options incorporated from the Predecessor Plan which do not otherwise contain such provisions. 
 D. The Plan shall terminate upon the earliest to occur of (i) November 6, 2009, (ii) the date on which all shares available for issuance under the Plan shall have been issued as fully vested shares or (iii) the
termination of all outstanding options in connection with a Corporate Transaction. Should the Plan terminate on November 6, 2009, then all option grants and unvested stock issuances outstanding at that time shall continue to have force and
effect in accordance with the provisions of the documents evidencing such grants or issuances. 
  

	IV.	AMENDMENT OF THE PLAN 

 A. The Board shall
have complete and exclusive power and authority to amend or modify the Plan in any or all respects. However, no such amendment or modification shall adversely affect the rights and obligations with respect to stock options or unvested stock
issuances at the time outstanding under the Plan unless the Optionee or the Participant consents to such amendment or modification. In addition, certain amendments may require stockholder approval pursuant to applicable laws or regulations.

 B. Options to purchase shares of Common Stock may be granted under the Discretionary Option Grant and Salary Investment Option
Grant Programs and shares of Common Stock may be issued under the Stock Issuance Program that are in each instance in excess of the number of shares then available for issuance under the Plan, provided any excess shares actually issued under those
programs shall be held in escrow until there is obtained stockholder approval of an amendment sufficiently increasing the number of shares of Common Stock available for issuance under the Plan. If such stockholder approval is not obtained within
twelve (12) months after the date the first such excess issuances are made, then (i) any unexercised options granted on the basis of such excess shares shall terminate and cease to be outstanding and (ii) the Corporation shall
promptly refund to the Optionees and the Participants the exercise or purchase price paid for any excess shares issued under the Plan and held in escrow, together with interest (at the applicable Short Term Federal Rate) for the period the shares
were held in escrow, and such shares shall thereupon be automatically cancelled and cease to be outstanding. 
  

	V.	USE OF PROCEEDS 

 Any cash proceeds received by the
Corporation from the sale of shares of Common Stock under the Plan shall be used for general corporate purposes. 
  

 25. 

	VI.	REGULATORY APPROVALS 

 A. The implementation
of the Plan, the granting of any stock option under the Plan and the issuance of any shares of Common Stock (i) upon the exercise of any granted option or (ii) under the Stock Issuance Program shall be subject to the Corporation’s
procurement of all approvals and permits required by regulatory authorities having jurisdiction over the Plan, the stock options granted under it and the shares of Common Stock issued pursuant to it. 
 B. No shares of Common Stock or other assets shall be issued or delivered under the Plan unless and until there shall have been compliance with
all applicable requirements of Federal and state securities laws, including the filing and effectiveness of the Form S-8 registration statement for the shares of Common Stock issuable under the Plan, and all applicable listing requirements of any
stock exchange (or the Nasdaq National Market, if applicable) on which Common Stock is then listed for trading. 
  

	VII.	NO EMPLOYMENT/SERVICE RIGHTS 

 Nothing in the Plan
shall confer upon the Optionee or the Participant any right to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Corporation (or any Parent or Subsidiary employing or
retaining such person) or of the Optionee or the Participant, which rights are hereby expressly reserved by each, to terminate such person’s Service at any time for any reason, with or without cause. 
  

 26. 

 APPENDIX 
 The following definitions shall be in effect under the Plan: 
 A. Automatic Option Grant
Program shall mean the automatic option grant program in effect under Article Five of the Plan. 
 B. Board
shall mean the Corporation’s Board of Directors. 
 C. Change in Control shall mean a change in ownership
or control of the Corporation effected through either of the following transactions: 
 (i) the acquisition, directly or indirectly by
any person or related group of persons (other than the Corporation or a person that directly or indirectly controls, is controlled by, or is under common control with, the Corporation), of beneficial ownership (within the meaning of Rule 13d-3 of
the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Corporation’s outstanding securities pursuant to a tender or exchange offer made directly to the Corporation’s
stockholders, or 
 (ii) a change in the composition of the Board over a period of thirty-six (36) consecutive months or less
such that a majority of the Board members ceases, by reason of one or more contested elections for Board membership, to be comprised of individuals who either (A) have been Board members continuously since the beginning of such period or
(B) have been elected or nominated for election as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the time the Board approved such election or nomination.

 D. Code shall mean the Internal Revenue Code of 1986, as amended. 
 E. Common Stock shall mean the Corporation’s common stock. 
 F. Corporate Transaction shall mean either of the following stockholder-approved transactions to which the Corporation is a party:

 (i) a merger or consolidation in which securities possessing more than fifty percent (50%) of the total combined voting power
of the Corporation’s outstanding securities are transferred to a person or persons different from the persons holding those securities immediately prior to such transaction, or 
 (ii) the sale, transfer or other disposition of all or substantially all of the Corporation’s assets in complete liquidation or dissolution
of the Corporation. 
 G. Corporation shall mean Sequenom, Inc., a Delaware corporation, and any corporate successor to
all or substantially all of the assets or voting stock of Sequenom, Inc. which shall by appropriate action adopt the Plan. 
 H.
Director Fee Option Grant Program shall mean the special stock option grant in effect for non-employee Board members under Article Six of the Plan. 
  

 A-1. 

 I. Discretionary Option Grant Program shall mean the discretionary option grant
program in effect under Article Two of the Plan. 
 J. Employee shall mean an individual who is in the employ of the
Corporation (or any Parent or Subsidiary), subject to the control and direction of the employer entity as to both the work to be performed and the manner and method of performance. 
 K. Exercise Date shall mean the date on which the Corporation shall have received written notice of the option exercise. 

L. Fair Market Value per share of Common Stock on any relevant date shall be determined in accordance with the following
provisions: 
 (i) If the Common Stock is at the time traded on the Nasdaq National Market, then the Fair Market Value shall be the
closing selling price per share of Common Stock on the date in question, as such price is reported by the National Association of Securities Dealers on the Nasdaq National Market and reported in The Wall Street Journal. If there is no closing
selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists. 
 (ii) If the Common Stock is at the time listed on any Stock Exchange, then the Fair Market Value shall be the closing selling price per share of
Common Stock on the date in question on the Stock Exchange determined by the Plan Administrator to be the primary market for the Common Stock, as such price is officially quoted in the composite tape of transactions on such exchange and reported in
The Wall Street Journal. If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists. 

(iii) For purposes of any option grants made on the Underwriting Date, the Fair Market Value shall be deemed to be equal to the price per
share at which the Common Stock is to be sold in the initial public offering pursuant to the Underwriting Agreement. 
 M.
Hostile Take-Over shall mean the acquisition, directly or indirectly, by any person or related group of persons (other than the Corporation or a person that directly or indirectly controls, is controlled by, or is under common
control with, the Corporation) of beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Corporation’s outstanding securities
pursuant to a tender or exchange offer made directly to the Corporation’s stockholders which the Board does not recommend such stockholders to accept. 
 N. Incentive Option shall mean an option which satisfies the requirements of Code Section 422. 
 O. Involuntary Termination shall mean the termination of the Service of any individual which occurs by reason of: 
 (i) such individual’s involuntary dismissal or discharge by the Corporation for reasons other than Misconduct, or 
  

 A-2. 

 (ii) such individual’s voluntary resignation following (A) a change in his or her
position with the Corporation which materially reduces his or her duties and responsibilities or the level of management to which he or she reports, (B) a reduction in his or her level of compensation (including base salary, fringe benefits and
target bonus under any corporate-performance based bonus or incentive programs) by more than fifteen percent (15%) or (C) a relocation of such individual’s place of employment by more than fifty (50) miles, provided and only if
such change, reduction or relocation is effected by the Corporation without the individual’s consent. 
 P. Misconduct
shall mean the commission of any act of fraud, embezzlement or dishonesty by the Optionee or Participant, any unauthorized use or disclosure by such person of confidential information or trade secrets of the Corporation (or any Parent or
Subsidiary), or any other intentional misconduct by such person adversely affecting the business or affairs of the Corporation (or any Parent or Subsidiary) in a material manner. The foregoing definition shall not be deemed to be inclusive of all
the acts or omissions which the Corporation (or any Parent or Subsidiary) may consider as grounds for the dismissal or discharge of any Optionee, Participant or other person in the Service of the Corporation (or any Parent or Subsidiary).

 Q. 1934 Act shall mean the Securities Exchange Act of 1934, as amended. 
 R. Non-Statutory Option shall mean an option not intended to satisfy the requirements of Code Section 422. 
 S. Optionee shall mean any person to whom an option is granted under the Discretionary Option Grant, Salary Investment Option Grant,
Automatic Option Grant or Director Fee Option Grant Program. 
 T. Parent shall mean any corporation (other than the
Corporation) in an unbroken chain of corporations ending with the Corporation, provided each corporation in the unbroken chain (other than the Corporation) owns, at the time of the determination, stock possessing fifty percent (50%) or more of
the total combined voting power of all classes of stock in one of the other corporations in such chain. 
 U.
Participant shall mean any person who is issued shares of Common Stock under the Stock Issuance Program. 
 V.
Permanent Disability or Permanently Disabled shall mean the inability of the Optionee or the Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment expected
to result in death or to be of continuous duration of twelve (12) months or more. However, solely for purposes of the Automatic Option Grant and Director Fee Option Grant Programs, Permanent Disability or Permanently Disabled shall mean the
inability of the non-employee Board member to perform his or her usual duties as a Board member by reason of any medically determinable physical or mental impairment expected to result in death or to be of continuous duration of twelve
(12) months or more. 
 W. Plan shall mean the Corporation’s 1999 Stock Incentive Plan, as set forth in this
document. 
  

 A-3. 

 X. Plan Administrator shall mean the particular entity, whether the Primary
Committee, the Board or the Secondary Committee, which is authorized to administer the Discretionary Option Grant and Stock Issuance Programs with respect to one or more classes of eligible persons, to the extent such entity is carrying out its
administrative functions under those programs with respect to the persons under its jurisdiction. 
 Y. Plan Effective
Date shall mean the date the Plan shall become effective and shall be coincident with the Underwriting Date. 
 Z.
Predecessor Plan shall mean the Corporation’s 1998 Stock Option/Stock Issuance Plan in effect immediately prior to the Plan Effective Date hereunder. 
 AA. Primary Committee shall mean the committee of two (2) or more non-employee Board members appointed by the Board to
administer the Discretionary Option Grant and Stock Issuance Programs with respect to Section 16 Insiders and to administer the Salary Investment Option Grant Program solely with respect to the selection of the eligible individuals who may
participate in such program. 
 BB. Salary Investment Option Grant Program shall mean the salary investment option grant
program in effect under Article Three of the Plan. 
 CC. Secondary Committee shall mean a committee of one or more
Board members appointed by the Board to administer the Discretionary Option Grant and Stock Issuance Programs with respect to eligible persons other than Section 16 Insiders. 
 DD. Section 16 Insider shall mean an officer or director of the Corporation subject to the short-swing profit liabilities of
Section 16 of the 1934 Act. 
 EE. Service shall mean the performance of services for the Corporation (or any
Parent or Subsidiary) by a person in the capacity of an Employee, a non-employee member of the board of directors or a consultant or independent advisor, except to the extent otherwise specifically provided in the documents evidencing the option
grant or stock issuance. 
 FF. Stock Exchange shall mean either the American Stock Exchange or the New York Stock
Exchange. 
 GG. Stock Issuance Agreement shall mean the agreement entered into by the Corporation and the Participant
at the time of issuance of shares of Common Stock under the Stock Issuance Program. 
 HH. Stock Issuance Program shall
mean the stock issuance program in effect under Article Four of the Plan. 
 II. Subsidiary shall mean any corporation
(other than the Corporation) in an unbroken chain of corporations beginning with the Corporation, provided each corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination, stock possessing fifty
percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. 
  

 A-4. 

 JJ. Take-Over Price shall mean the greater of (i) the Fair Market Value
per share of Common Stock on the date the option is surrendered to the Corporation in connection with a Hostile Take-Over or (ii) the highest reported price per share of Common Stock paid by the tender offeror in effecting such Hostile
Take-Over. However, if the surrendered option is an Incentive Option, the Take-Over Price shall not exceed the clause (i) price per share. 
 KK. 10% Stockholder shall mean the owner of stock (as determined under Code Section 424(d)) possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Corporation
(or any Parent or Subsidiary). 
 LL. Underwriting Agreement shall mean the agreement between the Corporation and the
underwriter or underwriters managing the initial public offering of the Common Stock. 
 MM. Underwriting Date shall
mean the date on which the Underwriting Agreement is executed and priced in connection with an initial public offering of the Common Stock. 
 NN. Withholding Taxes shall mean the Federal, state and local income and employment withholding taxes to which the holder of Non-Statutory Options or unvested shares of Common Stock may become subject in connection with
the exercise of those options or the vesting of those shares. 
  

 A-5.First Supplemental Indenture dated as of March 30, 2007

 EXHIBIT 4.1 
  

  
 FIRST
SUPPLEMENTAL INDENTURE 
 between 
 FIFTH THIRD BANCORP 
 and 
 WILMINGTON TRUST COMPANY 
  
 Dated as of March 30, 2007 
  
 Supplement to Junior Subordinated
Indenture, 
 dated as of March 20, 1997 
  
  

 TABLE OF CONTENTS 
  

					
	ARTICLE I DEFINITIONS	  	1
			
	 Section 1.1.
	 	Definitions	  	1
		
	ARTICLE II GENERAL TERMS AND CONDITIONS OF THE JSNS	  	10
			
	 Section 2.1.
	 	Designation, Principal Amount and Authorized Denomination	  	10
	 Section 2.2.
	 	Repayment	  	10
	 Section 2.3.
	 	Form	  	13
	 Section 2.4.
	 	Rate of Interest; Interest Payment Dates	  	13
	 Section 2.5.
	 	Interest Deferral	  	14
	 Section 2.6.
	 	Dividend and Other Payment Stoppages	  	15
	 Section 2.7.
	 	Alternative Payment Mechanism	  	16
	 Section 2.8.
	 	Redemption of the JSNs	  	19
	 Section 2.9.
	 	Events of Default	  	19
	 Section 2.10.
	 	Securities Registrar; Paying Agent; Delegation of Trustee Duties	  	20
	 Section 2.11.
	 	Limitation on Claims in the Event of Bankruptcy, Insolvency or Receivership	  	20
	 Section 2.12.
	 	Unconditional Right of Holders to Receive Principal, Premium and Interest; Direct Action by Holders of Trust Preferred Securities.	  	21
		
	ARTICLE III REPAYMENT OF JSNS	  	21
			
	 Section 3.1.
	 	Repayments	  	21
	 Section 3.2.
	 	Selection of the JSNs to be Repaid	  	21
	 Section 3.3.
	 	Notice of Repayment	  	22
	 Section 3.4.
	 	Deposit of Repayment Amount	  	22
	 Section 3.5.
	 	Repayment of JSNs	  	22
		
	ARTICLE IV EXPENSES	  	23
			
	 Section 4.1.
	 	Expenses	  	23
		
	ARTICLE V FORM OF JSNS	  	24
			
	 Section 5.1.
	 	Form of JSNs	  	24
		
	ARTICLE VI ORIGINAL ISSUE OF JSNS	  	30
			
	 Section 6.1.
	 	Original Issue of JSNs	  	30
	 Section 6.2.
	 	Calculation of Original Issue Discount	  	31

  

 -i- 

					
		
	ARTICLE VII SUBORDINATION	  	31
			
	 Section 7.1.
	 	Senior Debt	  	31
	 Section 7.2.
	 	Compliance with Federal Reserve Rules	  	32
		
	ARTICLE VIII MISCELLANEOUS	  	32
			
	 Section 8.1.
	 	Effectiveness	  	32
	 Section 8.2.
	 	Modification of Supplemental Indenture	  	32
	 Section 8.3.
	 	Miscellaneous	  	33
	 Section 8.4.
	 	Successors and Assigns	  	33
	 Section 8.5.
	 	Further Assurances	  	33
	 Section 8.6.
	 	Effect of Recitals	  	33
	 Section 8.7.
	 	Ratification of Indenture	  	33
	 Section 8.8.
	 	Governing Law	  	33

  

 -ii- 

 FIRST SUPPLEMENTAL INDENTURE, dated as
of March 30, 2007 (the “Supplemental Indenture”), between FIFTH THIRD BANCORP, an Ohio corporation (the “Company”), having its principal office
at Fifth Third Center, 38 Fountain Square Plaza, Cincinnati, Ohio 45263, and WILMINGTON TRUST COMPANY, as trustee (hereinafter called the “Trustee”). 
 RECITALS OF THE COMPANY 
 The Company and the Trustee entered into the Junior Subordinated Indenture, dated as of March 20, 1997 (the “Indenture”).

 Fifth Third Capital Trust IV, a Delaware statutory trust (the “Trust”), has offered to the public its trust preferred
securities known as 6.50% Trust Preferred Securities (the “Trust Preferred Securities”), which are beneficial interests in the Trust, and proposes to invest the proceeds from such offering, together with the proceeds of the issuance
and sale by the Trust to the Company of its common securities (the “Trust Common Securities” and, together with the Trust Preferred Securities, the “Trust Securities”), in the JSNs (as defined herein). 

Section 9.1 of the Indenture provides that the Company and the Trustee may, without the consent of any Holder, enter into a supplemental
indenture to establish the form or terms of securities of any series as permitted by Section 2.1 or 3.1 thereof. 
 Pursuant to Sections
2.1 and 3.1 of the Indenture, the Company desires to provide for the establishment of a new series of Securities under the Indenture, the form and substance of such Securities and the terms, provisions and conditions thereof to be set forth as
provided in the Indenture and this Supplemental Indenture. 
 The Company has delivered to the Trustee an Opinion of Counsel and an
Officers’ Certificate pursuant to Section 9.3 of the Indenture to the effect execution of this Supplemental Indenture is authorized or permitted by the Indenture. 
 The Company has requested that the Trustee execute and deliver this Supplemental Indenture and satisfy all requirements necessary to make this
Supplemental Indenture a valid instrument in accordance with its terms, and to make the JSNs, when executed by the Company and authenticated and delivered by the Trustee, the valid obligations of the Company and all acts and things necessary have
been done and performed to make this Supplemental Indenture enforceable in accordance with its terms, and the execution and delivery of this Supplemental Indenture has been duly authorized in all respects. 
 NOW, THEREFORE, THIS SUPPLEMENTAL INDENTURE WITNESSETH:
For and in consideration of the premises and the purchase of the JSNs by the Holders thereof, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders of the JSNs, as follows: 
 ARTICLE I 
 DEFINITIONS

 Section 1.1.        Definitions For all purposes of this Supplemental Indenture, except as
otherwise expressly provided or unless the context otherwise requires: 
 (a)        Terms defined in the Indenture or the Amended Declaration (as defined herein) have the same meaning when used in this Supplemental Indenture unless otherwise specified herein. 

 

 (b)        The terms defined in this Article have
the meanings assigned to them in this Article, and include the plural as well as the singular. 
 (c)        The words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Supplemental Indenture as a whole and not to any particular
Article, Section or other subdivision, and any reference to an Article, Section or other subdivision refers to an Article, Section or other subdivision of this Supplemental Indenture. 
 (d)        Any reference herein to “interest” includes any Additional Interest.

 “Amended Declaration” means the Amended and Restated Declaration of Trust, dated as of March 30, 2007, among the
Company, as Depositor, Wilmington Trust Company, as the Property Trustee and the Delaware Trustee, and the Administrative Trustees. 
 “Applicable Spread” means (i) 0.50% in the case of a redemption of all Outstanding JSNs at any time within 90 days after a Tax Event or Rating Agency Event and (ii) 0.30% in the case of any other redemption.

 “Business Combination” means a merger, consolidation, amalgamation or conveyance, transfer or lease of assets
substantially as an entirety by one Person to any other Person. 
 “Capital Treatment Event” means the Company’s
reasonable determination that, as a result of the occurrence of any amendment to, or change (including any announced prospective change) in, the laws (or any rules or regulations thereunder) of the United States or any political subdivision thereof
or therein, or as a result of any official or administrative pronouncement or action or judicial decision interpreting or applying such laws, rules or regulations, which amendment or change is effective or which pronouncement, action or decision is
announced on or after the date of issuance of the Trust Preferred Securities, there is more than an insubstantial risk that the Company will not be entitled to treat an amount equal to the aggregate liquidation amount of the Trust Preferred
Securities as “Tier 1 capital” (or the then equivalent thereof) for purposes of the capital adequacy guidelines of the Federal Reserve, as then in effect and applicable to the Company. 
 “Calculation Agent” means Wilmington Trust Company, or any other firm appointed by the Company, acting as calculation agent. 

“Commercially Reasonable Efforts” to sell Qualifying Capital Securities means commercially reasonable efforts to complete the offer
and sale of Qualifying Capital Securities to Persons other than Subsidiaries in public offerings or private placements. The Company will not be considered to have made Commercially Reasonable Efforts to effect a sale of Qualifying Capital Securities
if it determines not to pursue or complete such sale due to pricing, coupon, dividend rate or dilution considerations. 
 “Common
Stock” means the common stock of the Company. 
 “Common Equity Issuance Cap” has the meaning specified in
Section 2.7(a). 
 “Company” has the meaning specified in the Recitals. 
 “Current Stock Market Price” means, with respect to Common Stock on any date, (i) the closing sale price per share (or if no
closing sale price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and the average ask prices) on that date as reported in composite transactions by the Nasdaq Global Select
Market or if Common Stock is not then listed on the 

  

 -2- 

 
Nasdaq Global Select Market, as reported by the principal U.S. securities exchange on which Common Stock is traded or quoted on the relevant date,
(ii) if Common Stock is not listed on any U.S. securities exchange on the relevant date the last quoted bid price for Common Stock in the over-the-counter market on the relevant date as reported by the National Quotation Bureau or similar
organization, or (iii) if Common Stock is not so quoted the average of the mid-point of the last bid and ask prices for Common Stock on the relevant date from each of at least three nationally recognized independent investment banking firms
selected by the Company for this purpose. 
 “Deferral Period” means the period commencing on an Interest Payment Date with
respect to which the Company elects to defer interest pursuant to Section 2.5 and ending on the earlier of (i) the tenth anniversary of that Interest Payment Date and (ii) the next Interest Payment Date on which the Company has paid
the amount deferred, all deferred amounts with respect to any subsequent period and all other accrued and unpaid interest on the JSNs. The settlement of all deferred interest pursuant to Section 2.5(c), whether it occurs on an Interest Payment
Date or another date, will immediately terminate the Deferral Period. 
 “Eligible Proceeds” means, for each relevant
Interest Payment Date, the net proceeds (after deducting underwriters’ or placement agents’ fees, commissions or discounts and other expenses relating to the issuance or sale) the Company has received during the 180-day period prior to
such Interest Payment Date from the issuance or sale of Qualifying APM Securities (excluding sales of Common Stock in excess of the Maximum Share Number and sales of Qualifying Preferred Stock in excess of the Preferred Stock Issuance Cap,
respectively) to Persons that are not the Company’s Subsidiaries. 
 “Federal Reserve” means the Board of Governors of
the Federal Reserve System, together with the Federal Reserve Bank of Cleveland, Ohio, or any successor federal bank regulatory agency having primary jurisdiction over the Company. 
 “Final Repayment Date” has the meaning specified in Section 2.2(b). 
 “Fitch” means Fitch Ratings. 
 “Guarantee Agreement” means the Guarantee Agreement between the Company, as guarantor, and Wilmington Trust Company, as guarantee trustee, dated as of March 30, 2007. 
 “Indenture” has the meaning specified in the Recitals. 
 “Intent-Based Replacement Disclosure” has the meaning specified in the Replacement Capital Covenant. 
 “Interest Payment Date” has the meaning specified in Section 2.4. 
 “Interest
Period” means the period from, and including, any Interest Payment Date (or, in the case of the first Interest Period, March 30, 2007) to but excluding the next Interest Payment Date. 
 “Investment Company Event” means the receipt by the Trust of an opinion of counsel experienced in such matters to the effect that, as a
result of any amendment to, or change (including any announced prospective change) in, the laws (or any regulations thereunder) of the United States or any political subdivision or taxing authority thereof or therein, or as a result of any official
administrative pronouncement or judicial decision interpreting or applying such laws or regulations, which amendment or change is effective or which pronouncement or decision is announced on or after the date of issuance of the 

  

 -3- 

 
Trust Preferred Securities, there is more than an insubstantial risk that the Trust is or will be considered an “investment company” that is
required to be registered under the Investment Company Act of 1940, as amended. 
 “JSN” has the meaning specified in
Section 2.1. 
 “LIBOR” means, with respect to any monthly or quarterly Interest Period, the rate (expressed as a
percentage per annum) for deposits in U.S. dollars for a one- or three-month period, as applicable, commencing on the first day of that monthly or quarterly Interest Period that appears on the Reuters Screen LIBOR01 Page as of 11:00 a.m. (London
time) on the LIBOR Determination Date for that monthly or quarterly Interest Period, as the case may be. If such rate does not appear on Reuters Screen LIBOR01 Page, one- or three-month LIBOR will be determined on the basis of the rates at which
deposits in U.S. dollars for a one- or three-month period commencing on the first day of that monthly or quarterly Interest Period, as applicable, and in a principal amount of not less than $1,000,000 are offered to prime banks in the London
interbank market by four major banks in the London interbank market selected by the Calculation Agent (after consultation with the Company), at approximately 11:00 a.m., London time, on the LIBOR Determination Date for that monthly or quarterly
Interest Period. The Calculation Agent will request the principal London office of each of such banks to provide a quotation of its rate. If at least two such quotations are provided, one- or three-month LIBOR with respect to that monthly or
quarterly Interest Period, as applicable, will be the arithmetic mean (rounded upward if necessary to the nearest whole multiple of 0.00001%) of such quotations. If fewer than two quotations are provided, one- or three-month LIBOR with respect to
that monthly or quarterly Interest Period, as applicable, will be the arithmetic mean (rounded upward if necessary to the nearest whole multiple of 0.00001%) of the rates quoted by three major banks in New York City selected by the Calculation
Agent, at approximately 11:00 a.m., New York City time, on the first day of that monthly or quarterly Interest Period, as applicable, for loans in U.S. dollars to leading European banks for a one- or three-month period, as applicable, commencing on
the first day of that monthly or quarterly Interest Period and in a principal amount of not less than $1,000,000. However, if fewer than three banks selected by the Calculation Agent to provide quotations are quoting as described above, LIBOR for
that monthly or quarterly Interest Period will be the same as LIBOR as determined for the previous Interest Period or, in the case of the quarterly Interest Period beginning on April 15, 2017, 5.35%. The establishment of LIBOR for each monthly
or quarterly Interest Period, as applicable, by the Calculation Agent shall (in the absence of manifest error) be final and binding. 
 “LIBOR Determination Date” means the second London Banking Day immediately preceding the first day of the relevant monthly or quarterly Interest Period. 
 “London Banking Day” means any day on which commercial banks are open for general business (including dealings in deposits in U.S.
dollars) in London, England. 
 “Major Subsidiary Depository Institution” means a major subsidiary depository institution of
the Company within the meaning of the Federal Reserve’s risk-based capital guidelines applicable to bank holding companies. As of the date of this Supplemental Indenture, Fifth Third Bank and Fifth Third Bank (Michigan) are the Company’s
Major Subsidiary Depository Institutions. 
 “Make-Whole Redemption Price” is equal to 
 (x) 100% of the principal amount of the JSNs being redeemed, plus accrued and unpaid interest to the Redemption Date, or 
  

 -4- 

 (y) if greater, (A) in the case of a redemption prior to April 15, 2017, the sum of the present
values of the principal amount of the JSNs and each interest payment thereon that would have been payable to and including April 15, 2017 (not including any portion of such payments of interest accrued as of the Redemption Date), discounted
from April 15, 2017 or the applicable Interest Payment Date to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a discount rate equal to the Treasury Rate plus the Applicable Spread and,
(B) in the case of a redemption after April 15, 2017 and prior to but not including April 15, 2037, the sum of the present values of the principal amount and each interest payment thereon that would have been payable to and including
the next Ten-Year Date (not including any portion of such payments of interest accrued as of the Redemption Date), discounted from the next Ten-Year Date or the applicable Interest Payment Date to the Redemption Date on a quarterly basis (assuming a
360-day year consisting of twelve 30-day months) at a discount rate equal to the three-month LIBOR rate applicable to the immediately preceding Interest Period, as calculated by the Premium Calculation Agent, in each case of clauses (A) and
(B) above plus accrued and unpaid interest to the Redemption Date. 
 “Market Disruption Event” means, with respect to
the issuance or sale of Qualifying Capital Securities pursuant to Section 2.2 or Qualifying APM Securities pursuant to Section 2.7, the occurrence or existence of any of the following events or sets of circumstances: 
 (i)        Trading in securities generally (or in the Common Stock or Preferred Stock
specifically) on the New York Stock Exchange or any other national securities exchange, or in the over-the-counter market, on which Common Stock and/or Preferred Stock is then listed or traded shall have been suspended or the settlement of such
trading generally shall have been materially disrupted or minimum prices shall have been established on any such exchange or market by the relevant exchange or by any other regulatory body or governmental agency having jurisdiction, and the
establishment of such minimum prices materially disrupts or otherwise has a material adverse effect on trading in, or the issuance and sale of, Qualifying APM Securities or Qualifying Capital Securities, as the case may be; 
 (ii)        The Company would be required to obtain the consent or approval of a regulatory body
(including, without limitation, any securities exchange) or governmental authority to issue or sell Qualifying Capital Securities or Qualifying APM Securities, as the case may be, and such consent or approval has not yet been obtained
notwithstanding the Company’s commercially reasonable efforts to obtain such consent or approval; 
 (iii)        A banking moratorium shall have been declared by the federal or state authorities of the United States and such moratorium materially disrupts or otherwise has a material adverse effect
on trading in, or the issuance and sale of, the Qualifying APM Securities or Qualifying Capital Securities, as the case may be; 
 (iv)        A material disruption shall have occurred in commercial banking or securities settlement or clearance services in the United States and such disruption materially disrupts or otherwise has
a material adverse effect on trading in, or the issuance and sale of, the Qualifying APM Securities or Qualifying Capital Securities, as the case may be; 
 (v)        The United States shall have become engaged in hostilities, there shall have been an escalation in hostilities involving the United States, there shall have been a
declaration of a national emergency or war by the United States or there shall have 

  

 -5- 

 
occurred any other national or international calamity or crisis and such event materially disrupts or otherwise has a material adverse effect on trading in,
or the issuance and sale of, the Qualifying APM Securities or Qualifying Capital Securities, as the case may be; 
 (vi)        There shall have occurred such a material adverse change in general domestic or international economic, political or financial conditions, including as a result of terrorist activities,
and such change materially disrupts or otherwise has a material adverse effect on trading in, or the issuance and sale of, the Qualifying APM Securities or Qualifying Capital Securities, as the case may be; 
 (vii)        An event occurs and is continuing as a result of which the offering document for
such offer and sale of Qualifying APM Securities or Qualifying Capital Securities, as the case may be, would, in the reasonable judgment of the Company, contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading and either (a) the disclosure of that event at such time, in the reasonable judgment of the Company, is not otherwise required by law and would have a material adverse
effect on the business of the Company or (b) the disclosure relates to a previously undisclosed proposed or pending material business transaction, the disclosure of which would impede the ability of the Company to consummate such transaction,
provided that no single suspension period contemplated by this paragraph (vii) shall exceed 90 consecutive days and multiple suspension periods contemplated by this paragraph (vii) shall not exceed an aggregate of 90 days in any
180-day period; or 
 (viii)        The Company reasonably believes that the offering
document for such offer and sale of Qualifying APM Securities or Qualifying Capital Securities, as the case may be, would not be in compliance with a rule or regulation of the Commission (for reasons other than those referred to in paragraph
(vii) above) and the Company is unable to comply with such rule or regulation or such compliance is unduly burdensome, provided that no single suspension period contemplated by this paragraph (viii) shall exceed 90 consecutive days
and multiple suspension periods contemplated by this paragraph (viii) shall not exceed an aggregate of 90 days in any 180-day period. 
 “Maximum Share Number” has the meaning specified in Section 2.7(a)(iii). 
 “Moody’s”
means Moody’s Investors Service, Inc. 
 “Parity Securities” means debt securities or guarantees of the Company that
rank upon liquidation of the Company on a parity with the JSNs, and includes the JSNs. 
 “Paying Agent” means, with respect
to the JSNs, Wilmington Trust Company or any other Person, including an affiliate of the Company, authorized by the Company to pay the principal of or interest on the JSNs on behalf of the Company. 
 “Permitted Remedies” has the meaning specified in the Replacement Capital Covenant. 
 “Paying Agent Office” means the office of the applicable Paying Agent at which at any particular time its corporate agency business will
principally be administered in a Place of Payment, which office at the date hereof in the case of Wilmington Trust Company, in its capacity as Paying Agent with respect to 

  

 -6- 

 
the JSNs under the Indenture, is located at Wilmington Trust Company, Rodney Square North, 1100 North Market Street, Wilmington, Delaware 19890, Attention:
Corporate Trust Administration. 
 “Preferred Stock” means the preferred stock of the Company. 
 “Preferred Stock Issuance Cap” has the meaning specified in Section 2.7(a). 
 “Premium Calculation Agent” means Wilmington Trust Company, or if that firm is unwilling or unable to select the comparable treasury
issue, an investment banking institution of national standing appointed by the Property Trustee after consultation with the Company. 
 “Prospectus Supplement” means the prospectus supplement dated March 26, 2007 to the prospectus dated March 26, 2007, pursuant to which the Trust Preferred Securities and the JSNs were offered to investors.

 “Qualifying APM Securities” means Common Stock, Qualifying Preferred Stock and Qualifying Warrants. 
 “Qualifying Capital Securities” has the meaning specified in the Replacement Capital Covenant. 
 “Qualifying Preferred Stock” means non-cumulative perpetual preferred stock of the Company (a) as to which the transaction
documents provide for no remedies as a consequence of non-payment of distributions other than Permitted Remedies and (b) that (i) is subject to Intent-Based Replacement Disclosure and has a provision that prohibits the Company from making
any distributions thereon upon its failure to satisfy one or more financial tests set forth therein or (ii) is subject to a Qualifying Replacement Capital Covenant. 
 “Qualifying Replacement Capital Covenant” has the meaning specified in the Replacement Capital Covenant. 
 “Qualifying Warrants” means net share settled warrants to purchase Common Stock that (a) have an exercise price greater than the Current Stock Market Price as of the date the Company agrees to
issue such warrants and (b) the Company is not entitled to redeem for cash and the holders of which are not entitled to require it to repurchase for cash in any circumstances. 
 A “Rating Agency Event” means an amendment, clarification or change has occurred in the equity credit criteria for securities such as
the JSNs of any nationally recognized statistical rating organization within the meaning of Rule 15c3-1 under the Exchange Act that then publishes a rating for the Company (in this definition, a “rating agency”), which amendment,
clarification or change results in a lower equity credit for the JSNs than the then respective equity credit assigned by such rating agency on the date hereof. 
 “Repayment Date” means the Scheduled Maturity Date and each Interest Payment Date thereafter until the Company shall have repaid or redeemed all of the JSNs. 
 “Replacement Capital Covenant” means the Replacement Capital Covenant, dated as of March 30, 2007, by the Company, as the same may
be amended or supplemented from time to time in accordance with the provisions thereof and Section 2.2(a)(viii). 
 “Responsible
Officer” means, with respect to Wilmington Trust Company in its capacity as Paying Agent, any officer within the Corporate Trust Department (or any successor department, unit or division of Wilmington Trust Company) assigned to the Paying
Agent Office of Wilmington Trust Company, in its 

  

 -7- 

 
capacity as Paying Agent, who has direct responsibility for the administration of the Paying Agent functions of the Indenture. 
 “Reuters Screen LIBOR01 Page” means the display designated on the Reuters Screen LIBOR01 Page (or such other page as may replace the
Reuters Screen LIBOR01 Page on the service or such other service as may be nominated by the British Bankers’ Association for the purpose of displaying London interbank offered rates for U.S. Dollar deposits). 
 “S&P” means Standard & Poor’s Ratings Services, a division of McGraw Hill, Inc. 
 “Scheduled Maturity Date” means April 15, 2037, as such date may be extended in accordance with clause (ii) of
Section 2.2(a). 
 “Securities Registrar” means, with respect to the JSNs, Wilmington Trust Company, or any other firm
appointed by the Company, acting as securities registrar for the JSNs. 
 “Securities Registrar Office” means the office of
the applicable Securities Registrar at which at any particular time its corporate agency business will principally be administered, which office at the date hereof in the case of Wilmington Trust Company, in its capacity as Securities Registrar
under the Indenture, is located at Wilmington Trust Company, Rodney Square North, 1100 North Market Street, Wilmington, Delaware 19890, Attention: Corporate Trust Administration. 
 A “Supervisory Event” shall commence on the date the Company has notified the
Federal Reserve of its intention and affirmatively requested Federal Reserve approval both (1) to sell Qualifying APM Securities and (2) to apply the net proceeds of such sale to pay deferred interest on the JSNs, and the Company has been
notified that the Federal Reserve disapproves of either of these actions, and shall cease on the Business Day following the earlier to occur of (i) the 10th anniversary of the commencement of any Deferral Period or (ii) the day on which the Federal Reserve notifies the Company in writing that it no longer disapproves of the Company’s intention
to both (1) issue or sell Qualifying APM Securities and (2) apply the net proceeds from such sale to pay deferred interest on the JSNs. 
 “Supplemental Indenture” means this instrument as originally executed or as it may from time to time be supplemented or amended by one or more agreements supplemental hereto entered into pursuant to the applicable
provisions hereof. 
 “Tax Event” means that the Company has requested and received an opinion of counsel experienced in
such matters to the effect that, as a result of any: 
 (i)        amendment to or
change (including any announced prospective change) in the laws or regulations of the United States or any political subdivision or taxing authority of or in the United States that is enacted or becomes effective after the initial issuance of the
Trust Preferred Securities; 
 (ii)        proposed change in those laws or
regulations that is announced after the initial issuance of the Trust Preferred Securities; 
 (iii)        official administrative decision or judicial decision or administrative action or other official pronouncement interpreting or applying those laws or regulations that is announced after
the initial issuance of the Trust Preferred Securities; or 
  

 -8- 

 (iv)        threatened challenge asserted in
connection with an audit of the Trust, the Company or its Subsidiaries, or a threatened challenge asserted in writing against any other taxpayer that has raised capital through the issuance of securities that are substantially similar to the JSNs or
the Trust Preferred Securities; 
 there is more than an insubstantial increase in risk that: 
 (i)        the Trust is or will be subject to United States federal income tax with respect to
income received or accrued on the JSNs; 
 (ii)        interest payable by the
Company on the JSNs is not, or will not be, deductible by the Company, in whole or in part, for United States federal income tax purposes; or 
 (iii)        the Trust is or will be subject to more than a de minimis amount of other taxes, duties or other governmental charges. 
 “Ten-Year Date” means April 15, 2027 or April 15, 2037. 
 “Trading Day” means a day on which Common Stock is traded on the Nasdaq Global Select Market, or if not then listed on the Nasdaq Global
Select Market, a day on which Common Stock is traded or quoted on the principal U.S. securities exchange on which it is listed or quoted, or if not then listed or quoted on a U.S. securities exchange, a day on which Common Stock is quoted in the
over-the-counter market. 
 “Treasury Dealer” means Goldman, Sachs & Co. (or its successor) or, if Goldman,
Sachs & Co. (or its successor) refuses to act as treasury dealer for this purpose or ceases to be a primary U.S. Government securities dealer, another nationally recognized investment banking firm that is a primary U.S. Government
securities dealer specified by us for these purposes. 
 “Treasury Rate” means the semi-annual equivalent yield to maturity
of the Treasury Security that corresponds to the Treasury Price (calculated in accordance with standard market practice and computed as of the second trading day preceding the Redemption Date). 
 “Treasury Security” means the United States Treasury security that the Treasury Dealer determines would be appropriate to use, at the
time of determination and in accordance with standard market practice, in pricing the JSNs being redeemed in a tender offer based on a spread to United States Treasury yields. 
 “Treasury Price” means the bid-side price for the Treasury Security as of the third trading day preceding the Redemption Date, as set
forth in the daily statistical release (or any successor release) published by the Federal Reserve Bank of New York on that trading day and designated “Composite 3:30 p.m. Quotations for U.S. Government Securities”, except that:
(i) if that release (or any successor release) is not published or does not contain that price information on that trading day; or (ii) if the Treasury Dealer determines that the price information is not reasonably reflective of the actual
bid-side price of the Treasury Security prevailing at 3:30 p.m., New York City time, on that trading day, then Treasury Price will instead mean the bid-side price for the Treasury Security at or around 3:30 p.m., New York City time, on that trading
day (expressed on a next trading day settlement basis) as determined by the Treasury Dealer through such alternative means as the Treasury Dealer considers to be appropriate under the circumstances. 
 “Trust” has the meaning specified in the Recitals. 
  

 -9- 

 “Trust Common Securities” has the meaning specified in the Recitals. 
 “Trustee” has the meaning specified in the Recitals. 
 “Trust Preferred Securities” has the meaning specified in the Recitals. 
 “Trust
Securities” has the meaning specified in the Recitals. 
 “Underwriting Agreement” means the Underwriting
Agreement, dated as of March 26, 2007, among the Trust, the Company and the underwriters named therein. 
 ARTICLE II 
 GENERAL TERMS AND CONDITIONS OF THE JSNS

 Section 2.1.        Designation, Principal Amount and Authorized Denomination 

There is hereby authorized a series of Securities designated the Junior Subordinated Notes (the “JSNs”), the amount of which to be
issued will be as set forth in any Corporation Order for the authentication and delivery of JSNs pursuant to the Indenture. The denominations in which JSNs will be issuable are $1,000 principal amount and integral multiples thereof. The maximum
aggregate principal amount of JSNs that may be authenticated and delivered under the Indenture and this Supplemental Indenture is $750,010,000 (except for JSNs authenticated and delivered upon registration of transfer of, or exchange for, or in lieu
of, other JSNs pursuant to Section 3.4, 3.6, 3.7, 9.6 or 11.6 of the Indenture or Section 3.5 of this Supplemental Indenture); provided, however, that the Company may from time to time authenticate and deliver under the
Indenture and this Supplemental Indenture up to $149,990,000 additional principal amount of JSNs, which JSNs may accrue interest from a different date than the JSNs, as may be specified pursuant to Section 3.1 of the Indenture, so long as the
Company reasonably determines that the additional JSNs so authenticated and delivered will be fungible for United States federal income tax purposes and, if the JSNs are held by the Property Trustee, subject to the satisfaction of the conditions set
forth in the Amended Declaration with respect to the issuance of additional Trust Preferred Securities. From time to time the Company may execute and deliver, and upon Corporation Order the Trustee shall authenticate and deliver, additional JSNs.

 Section 2.2.        Repayment 
 (a)        Scheduled Maturity Date. 
 (i)        The principal amount of, and all accrued and unpaid interest on, the JSNs will be
payable in full on the Scheduled Maturity Date; provided, however, that in the event the Company has delivered an Officers’ Certificate to the Trustee pursuant to clause (vi) of this Section 2.2(a) in connection with the
Scheduled Maturity Date, (x) the principal amount of JSNs payable on the Scheduled Maturity Date, if any, will be the principal amount set forth in the notice of repayment, if any, accompanying such Officers’ Certificate, (y) such
principal amount of JSNs will be repaid on the Scheduled Maturity Date pursuant to Article III, and (z) subject to clause (iii) of this Section 2.2(a), the remaining JSNs will remain outstanding and will be payable on the immediately
succeeding Interest Payment Date or such earlier date on which they are redeemed pursuant to Section 2.8 or become due and payable pursuant to Section 5.2 of the Indenture. The entire principal amount of the JSNs outstanding will be due
and payable on 

  

 -10- 

 
the Scheduled Maturity Date in the event the Company does not deliver an Officers’ Certificate to the Trustee during the period from and including the
30th Business Day immediately preceding the Scheduled Maturity Date to and including the 10th Business Day immediately preceding the Scheduled Maturity Date. 
 (ii)        The Company may elect to extend the initial Scheduled Maturity Date to April 15,
2047, if all the following criteria are satisfied: 
 (A)        On April 15,
2017, the Trust Preferred Securities or the JSNs are rated at least Baa3 by Moody’s or BBB- by either of S&P or Fitch or, if any of Moody’s, S&P and Fitch Ratings (or their respective successors) is no longer in existence, the
equivalent rating by any other nationally recognized statistical rating organization within the meaning of 15c3-1 under the Exchange Act of 1934, as amended. 
 (B)        During the three years prior to April 15, 2017: (x) no event of default has
occurred or is occurring in respect of any payment obligation on, or financial covenant in, any of the Company’s then outstanding debt for money borrowed having an aggregate principal amount of $100 million or greater; and (y) the Company
did not have (and does not currently have) any outstanding deferred payments under any of its then outstanding Preferred Stock or debt for money borrowed. 
 No modification of the foregoing criteria will be effective against any Holder of the JSNs without its consent. If any date that would be the Scheduled Maturity Date as determined pursuant to this clause (ii) is
not a Business Day, the Scheduled Maturity Date will be the next following Business Day. 
 (iii)        In the event the Company has delivered an Officers’ Certificate to the Trustee pursuant to clause (vi) of this Section 2.2(a) in connection with any
Interest Payment Date after the Scheduled Maturity Date, the principal amount of JSNs repayable on such Interest Payment Date will be the principal amount set forth in the notice of repayment, if any, accompanying such Officers’ Certificate,
and will be repaid on such Interest Payment Date pursuant to Article III, and the remaining JSNs will remain outstanding and will be payable on the immediately succeeding Interest Payment Date or such earlier date on which they are redeemed pursuant
to Section 2.8 or become due and payable pursuant to Section 5.2 of the Indenture. The entire principal amount of the JSNs outstanding will be due and payable on any Interest Payment Date after the Scheduled Maturity Date in the event the
Company does not deliver an Officers’ Certificate to the Trustee during the period from and including the 30th
Business Day immediately preceding such Interest Payment Date to and including the 5th Business Day immediately
preceding such Interest Payment Date. 
 (iv)        The obligation of the Company to
repay the JSNs pursuant to this Section 2.2(a) on any date before the Final Repayment Date will be subject to (x) its obligations under Article XIII of the Indenture to the holders of Senior Debt and (y) its obligations under
Section 2.5 with respect to the payment of deferred interest on the JSNs. 
 (v)        Until the JSNs are paid in full, the Company will use Commercially Reasonable Efforts, subject to a Market Disruption Event: 
  

 -11- 

 (A)        to raise sufficient net proceeds from
the issuance of Qualifying Capital Securities during a 180-day period ending on the date, not more than 30 and not less than 10 Business Days before the Scheduled Maturity Date, on which the Company delivers the notice required by clause
(vi) of this Section 2.2(a) and Section 3.1, to permit repayment of the JSNs in full on the Scheduled Maturity Date pursuant to clause (i) of this Section 2.2(a); and 
 (B)        if the Company is unable for any reason to raise sufficient proceeds from the
issuance of Qualifying Capital Securities to permit repayment in full of the JSNs on the Scheduled Maturity Date (as required by clause (A) above) or any subsequent Interest Payment Date, to raise sufficient net proceeds from the issuance of
Qualifying Capital Securities during a 90-day period ending on the date, not more than 30 and not less than 10 Business Days before the following Interest Payment Date, on which the Company delivers the notice required by clause (vi) of this
Section 2.2(a) and Section 3.1, to permit repayment of the JSNs in full on such following Interest Payment Date pursuant to clause (i)(z) of this Section 2.2(a). 
 (vi)        The Company shall, if it has not raised sufficient net proceeds from the issuance of
Qualifying Capital Securities pursuant to clause (iv) above in connection with any Repayment Date, deliver an Officers’ Certificate to the Trustee (which the Trustee shall promptly forward upon receipt to the Property Trustee) no more than
15 and no less than 10 Business Days in advance of such Repayment Date stating the amount of net proceeds, if any, raised pursuant to clause (v) above in connection with such Repayment Date and the corresponding principal amount of the JSNs
represented thereby. The Company shall be excused from its obligation to use Commercially Reasonable Efforts to sell Qualifying Capital Securities pursuant to clause (v) above if such Officers’ Certificate further certifies that:
(A) a Market Disruption Event was existing during the 180-day period preceding the date of such Officers’ Certificate or, in the case of any Repayment Date after the Scheduled Maturity Date, the 90-day period (or if the Scheduled Maturity
Date has been extended to April 15, 2047, the 30-day period) preceding the date of such Officers’ Certificate; and (B) either (1) the Market Disruption Event continued for the entire 180-, 90- or 30-day period, as the case may
be, or (2) the Market Disruption Event continued for only part of the period, but the Company was unable after Commercially Reasonable Efforts to raise sufficient net proceeds during the rest of that period to permit repayment of the JSNs in
full pursuant to clause (v) above. Each Officers’ Certificate delivered pursuant to this clause (vi), unless no principal amount of JSNs is to be repaid on the applicable Repayment Date, will be accompanied by a notice of repayment
pursuant to Section 3.1 setting forth the principal amount of the JSNs to be repaid on such Repayment Date, if any, which amount will be determined after giving effect to clause (vii) of this Section 2.2(a). 
 (vii)        Payments in respect of the JSNs on any Repayment Date will be applied, first, to
deferred interest to the extent of Eligible Proceeds raised pursuant to Section 2.7, second, to pay current interest to the extent not paid from other sources and, third, to the principal of the JSNs; provided that if the Company is
obligated to sell Qualifying Capital Securities and make payments of principal on any outstanding securities in addition to the JSNs in respect thereof, then on any date and for any period such payments will be applied to the JSNs and those other
securities having the same scheduled maturity date as the JSNs pro rata in accordance with their respective outstanding principal amounts and no such 

  

 -12- 

 
payments will be made to any other securities having a later scheduled maturity date until the principal of the JSNs has been paid in full, except to the
extent permitted by Section 2.6(a) and 2.7(c). Notwithstanding the foregoing, if the Company raises less than $5 million of net proceeds from the sale of Qualifying Capital Securities during the relevant 180-, 90- or 30-day period, the Company
will not be required to repay any JSNs on the applicable Repayment Date. On the next Interest Payment Date as of which the Company has raised at least $5 million of net proceeds during the 180-day period preceding the applicable notice date (or, if
shorter, the period since the Company last repaid any principal amount of JSNs), the Company shall be required to repay a principal amount of the JSNs equal to the entire net proceeds from the sale of Qualifying Capital Securities during such
180-day or shorter period. 
 (viii)        The Company shall not amend the
Replacement Capital Covenant to amend the definitions incorporated into this Supplemental Indenture pursuant to Section 1.1 or to impose additional restrictions on the type or amount of Qualifying Capital Securities that the Company may include
for purposes of determining when repayment, redemption or purchase of the JSNs or the Trust Preferred Securities is permitted, except with the consent of holders of a majority by liquidation amount of the Trust Preferred Securities or, if the JSNs
have been distributed by the Trust to the holders of the Trust Preferred Securities, a majority by principal amount of the JSNs. Except as aforesaid, the Company may amend or supplement the Replacement Capital Covenant in accordance with its terms
and without the consent of the holders of the Trust Preferred Securities or the JSNs. 
 (b)        Final Repayment Date. The principal of, and all accrued and unpaid interest on, all outstanding JSNs will be due and payable on April 1, 2067 or, if such day is not a Business
Day, the following Business Day (the “Final Repayment Date”), regardless of the amount of Qualifying Capital Securities or Qualifying APM Securities the Company may have issued and sold by that time. 
 Section 2.3.        Form 
 The JSNs will be issued in fully registered definitive form without interest coupons. Principal of and interest on the JSNs issued in definitive form will be payable, the transfer of such JSNs will be registrable and
such JSNs will be exchangeable for JSNs bearing identical terms and provisions and notices and demands to or upon the Company in respect of the JSNs and the Indenture may be served at the Corporate Trust Office of the Trustee, and the Company
appoints the Trustee as its agent for the foregoing purposes, provided that payment of interest may be made at the option of the Company by check mailed to the Holder at such address as will appear in the Securities Register or by wire
transfer in immediately available funds to the bank account number of the Holder specified in writing by the Holder not less than 10 days before the relevant Interest Payment Date and entered in the Securities Register by the Securities Registrar,
provided, further, that if the Property Trustee, on behalf of the Trust, is the sole Holder of the JSNs then payment of interest will be made by wire transfer in immediately available funds to a bank account number specified by the Property
Trustee. The JSNs may be presented for registration of transfer or exchange at the Securities Registrar Office. 
 Section
2.4.        Rate of Interest; Interest Payment Dates 
 (a)        Rate of Interest. The JSNs will bear interest at the rate of (i) 6.50% per annum, from and including March 30, 2007 to but excluding April 15, 2017,
(ii) an annual rate equal to 

  

 -13- 

 
three-month LIBOR plus 1.3675%, from and including April 15, 2017 to but excluding April 15, 2047, and (iii) an annual rate equal to one-month
LIBOR plus 2.3675% thereafter. The interest will accrue from March 30, 2007 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, as the case may be, until the principal thereof is paid or made
available for payment. Interest will be computed on the basis of (i) a 360-day year comprised of twelve 30-day months with respect to any Interest Period ending on or prior to April 15, 2017 and (ii) a 360-day year and the actual
number of days elapsed with respect to any other Interest Period. Accrued interest that is not paid on the applicable Interest Payment Date (after giving effect to the adjustments described in the last sentence of Section 2.4(b)), including
interest deferred pursuant to Section 2.5, will bear Additional Interest, to the extent permitted by law, at the then-applicable rate described in this paragraph from the relevant Interest Payment Date, compounded on each subsequent Interest
Payment Date. 
 (b)         Interest Payment Dates. Subject to the other
provisions hereof, interest on the JSNs will be payable (i) semi-annually in arrears on April 15 and October 15 of each year, beginning on October 15, 2007 until April 15, 2017, (ii) quarterly in arrears on
January 15, April 15, July 15, and October 15 of each year, beginning on July 15, 2017 until April 15, 2047; and (iii) monthly in arrears on the 15th day of each month thereafter (each such date, an
“Interest Payment Date”); provided, however, if any Interest Payment Date described in clauses (ii) or (iii) of this paragraph falls on a day that is not a Business Day, the applicable Interest Payment Date
shall instead occur on the immediately succeeding Business Day. If any Interest Payment Date scheduled on or prior to the regularly scheduled Interest Payment Date in April, 2017 occurs on a day that is not a Business Day, the payment of interest
for such Interest Payment Date shall be made (or such interest shall be made available for payment) on the next succeeding Business Day with the same force and effect as if such payment were made on the relevant Interest Payment Date. 
 Section 2.5.        Interest Deferral 
 (a)        Option to Defer Interest Payments. The following provisions shall apply to the
JSNs in lieu of Section 3.11 and the first paragraph of Section 10.7 of the Indenture: 
 (i)        The Company will have the right at any time and from time to time, to defer the payment of interest on the JSNs for one or more consecutive Interest Periods up to 10 years; provided
that no Deferral Period will extend beyond the Final Repayment Date or the earlier redemption of the JSNs. Upon termination of any Deferral Period and upon the payment of all deferred interest then due on any Interest Payment Date, the Company may
elect to begin a new Deferral Period pursuant to this Section 2.5. 
 (ii)        At the end of any Deferral Period, the Company will pay all deferred interest on the JSNs to the Persons in whose names the JSNs are registered in the Securities Register at the close of
business on the Regular Record Date with respect to the Interest Payment Date at the end of such Deferral Period. 
 (iii)        The Company may elect to pay interest on any Interest Payment Date during any Deferral Period to the extent permitted by Section 2.5(b). 
 (b)        Payment of Deferred Interest. The Company will not pay deferred interest on the
JSNs before the Final Repayment Date or at any time an Event of Default has occurred and is continuing from any source other than Eligible Proceeds. Notwithstanding the foregoing, (i) the Company may pay current interest during a Deferral
Period or at any other time from any available 

  

 -14- 

 
funds and (ii) if a Supervisory Event has occurred and is continuing, then the Company may (but is not obligated to) pay deferred interest with cash
from any source. In addition, if the Company sells Qualifying APM Securities pursuant to Section 2.7 but a Supervisory Event arises from the Federal Reserve disapproving the use of the proceeds to pay deferred interest, the Company may use the
proceeds for other purposes and continue to defer interest on the JSNs. 
 (c)        Business Combination Exception. If the Company is involved in a Business Combination where immediately after its consummation more than 50% of the voting stock of the Person formed
by such Business Combination, or the Person that is the surviving entity of such Business Combination, or the Person to whom such properties and assets are conveyed, transferred or leased in such Business Combination, is owned by the shareholders of
the other party to such Business Combination, then Section 2.5(b) and Section 2.7 will not apply to any Deferral Period that is terminated on the next Interest Payment Date following the date of consummation of such Business Combination
(or if later, at any time within 90 days following the date of consummation of the Business Combination). The Company will establish a Special Record Date for the payment of any deferred interest pursuant to this Section 2.5(c) on a date other
than an Interest Payment Date. 
 (d)        Notice of Deferral. The Company
will give written notice of its election to begin or extend any Deferral Period, (x) if the Property Trustee, on behalf of the Trust, is the sole Holder of the JSNs, to the Property Trustee and the Delaware Trustee no more than 30 and no less
than five Business Days before the earlier of (A) the next succeeding date on which the distributions on the Trust Preferred Securities are payable and (B) the date the Property Trustee is required to give notice to holders of the Trust
Preferred Securities of the record or payment date for the related distribution, or (y) if the Property Trustee, on behalf of the Trust, is not the sole Holder of the JSNs, to each Holder of the JSNs and the Trustee no more than 30 and no less
than five Business Days before the next Interest Payment Date. Notice of the Company’s election of a Deferral Period will be given by the Property Trustee by first-class mail, postage prepaid, mailed not less than three Business Days after the
Property Trustee receives written notice from the Company to each holder of Trust Securities at such holder’s address appearing in the Security Register. 
 Section 2.6.        Dividend and Other Payment Stoppages 
 (a)        During Deferral Period. So long as any JSNs remain Outstanding, if the Company has given notice of its election to defer interest payments on the JSNs but the
related Deferral Period has not yet commenced or a Deferral Period is continuing, the Company will not, and will not permit any Subsidiary to: 
 (i)        declare or pay any dividends or distributions, or redeem, purchase, acquire or make a liquidation payment with respect to, any shares of capital stock of the Company;

 (ii)        make any payment of principal of or interest or premium, if any, on or
repay, purchase or redeem any Parity Securities or any debt securities or guarantees of the Company that ranks pari passu with or junior in interest upon liquidation to the JSNs; or 
 (iii)        make any payments under any guarantee by the Company that ranks junior to the
Guarantee Agreement; 
 provided, however, the restrictions in clauses (i), (ii) and (iii) above do not apply to: (1) any purchase,
redemption or other acquisition of shares of the Company’s capital stock by the Company in connection 

  

 -15- 

 
with (A) any employment contract, benefit plan or other similar arrangement with or for the benefit of any one or more of its employees, officers,
directors or consultants, (B) a dividend reinvestment or shareholder purchase plan, (C) transactions effected by or for the account of customers of the Company or any of its affiliates or in connection with the distribution, trading or
market-making in respect of the Trust Preferred Securities or (D) the issuance of the Company’s capital stock, or securities convertible into or exercisable for such capital stock, as consideration in an acquisition transaction entered
into before the applicable Deferral Period, (2) any exchange or conversion of any class or series of the Company’s capital stock, or the capital stock of one of its Subsidiaries, for any other class or series of its capital stock, or of
any class or series of its indebtedness for any class or series of its capital stock, (3) any purchase of fractional interests in shares of the Company’s capital stock pursuant to the conversion or exchange provisions of such capital stock
or the securities being converted or exchanged, (4) any declaration of a dividend in connection with any shareholder rights plan, or the issuance of rights, stock or other property under any shareholder rights plan, or the redemption or
purchase of rights pursuant thereto, (5) any dividend in the form of stock, warrants, options or other rights where the dividend stock or stock issuable upon exercise of such warrants, options or other rights is the same stock as that on which
the dividend is being paid or ranks equally with or junior to such stock, (6) any payment of current or deferred interest on Parity Securities that is made pro rata to the amounts due on such Parity Securities (including the JSNs),
provided that such payments are made in accordance with Section 2.7(c) to the extent it applies, and any payment of deferred interest on Parity Securities that, if not made, would cause the Company to breach the terms of the instrument
governing such Parity Securities, or (7) any payment of principal in respect of Parity Securities having the same scheduled maturity date as the Scheduled Maturity Date for the JSNs, as required under a provision of such other Parity Securities
that is substantially the same as the provision described under Section 2.2, and that is made on a pro rata basis among one or more series of Parity Securities (including the JSNs) having such a provision. The distribution restrictions
and exceptions in this Section 2.6 will be in lieu of the distribution restrictions and exceptions in Section 3.12 of the Indenture. 
 (b)        Additional Limitation upon Deferral Lasting over One Year. If any Deferral Period lasts longer than one year, the Company will not repurchase or acquire any
securities ranking junior to or pari passu with any Qualifying APM Securities the proceeds of which were used to settle deferred interest during the relevant Deferral Period before the first anniversary of the date on which all deferred
interest on the JSNs has been paid, subject to the exceptions listed in clauses (1) through (7) of Section 2.6(a). However, if the Company is involved in a Business Combination where immediately after its consummation more than 50% of
the voting stock of the Person formed by such Business Combination, or the Person that is the surviving entity of such Business Combination, or the Person to whom such properties and assets are conveyed, transferred or leased in such Business
Combination, is owned by the shareholders of the other party to such Business Combination, then the limitation set forth in this Section 2.6(b) will not apply to any Deferral Period that is terminated on the next Interest Payment Date following
the date of consummation of such Business Combination (or if later, at any time within 90 days following the date of consummation of the Business Combination). 
 Section 2.7.        Alternative Payment Mechanism 
 (a)        Obligation to Issue Qualifying APM Securities. Commencing not later than the earlier of (i) the first Interest Payment Date following the commencement of any Deferral Period on
which the Company pays any current interest on the JSNs from any source of funds or (ii) the fifth anniversary of the commencement of such Deferral Period, the Company shall, subject to the occurrence and continuation of a Supervisory Event or
a Market Disruption Event as described under Section 2.7(b) and subject to Section 2.5(c), issue one or more types of Qualifying APM Securities until the Company has raised an amount of Eligible Proceeds at least equal to the 

  

 -16- 

 
aggregate amount of accrued and unpaid deferred interest on the JSNs and applied such Eligible Proceeds on the next Interest Payment Date to the payment of
deferred interest in accordance with Section 2.5, provided that: 
 (i)        the foregoing obligations will not apply to the extent that, with respect to deferred interest attributable to the first five years of any Deferral Period, the net proceeds of any issuance
of Common Stock (or Qualifying Warrants if the definition of Qualifying APM Securities has been modified to exclude Common Stock) applied during such Deferral Period to pay interest on the JSNs pursuant to this Section 2.7, together with the
net proceeds of all prior issuances of Common Stock and Qualifying Warrants so applied during such Deferral Period, would exceed an amount equal to 2% of the product of the average of the Current Stock Market Prices of the Common Stock on the 10
consecutive Trading Days ending on the second Trading Day immediately preceding the date of issuance multiplied by the total number of issued and outstanding shares of Common Stock as of the date of the Company’s then most recent publicly
available consolidated financial statements (the “Common Equity Issuance Cap”); provided that the Common Equity Issuance Cap will cease to apply after the ninth anniversary of the commencement of any Deferral Period, at which
point the Company must pay any deferred interest regardless of the time at which it was deferred, pursuant to this Section 2.7, subject to the Maximum Share Number and any Supervisory Event or Market Disruption Event; and provided,
further, that if the Common Equity Issuance Cap is reached during a Deferral Period and the Company subsequently repays all deferred interest, the Common Equity Issuance Cap will cease to apply at the termination of such Deferral Period and
will not apply again unless and until the Company starts a new Deferral Period; and 
 (ii)        the Company shall not be permitted to issue Qualifying Preferred Stock to pay deferred interest on the JSNs, and the foregoing obligations will not apply, to the extent that the net
proceeds of any issuance of Qualifying Preferred Stock applied to pay interest on the JSNs pursuant to this Section 2.7, together with the net proceeds of all prior issuances of Preferred Stock so applied during the current and all prior
Deferral Periods, would exceed 25% of the aggregate principal amount of the outstanding JSNs (the “Preferred Stock Issuance Cap”); and 
 (iii)        the Company shall not be permitted to sell more than 200 million shares of Common Stock (such number, as it may be adjusted from time to time, the
“Maximum Share Number”) for purposes of paying deferred interest on the JSNs; provided that if the issued and outstanding shares of Common Stock shall have been changed into a different number of shares or a different class by
reason of any stock split, reverse stock split, stock dividend, reclassification, recapitalization, split-up, combination, exchange of shares or other similar transaction, then the Maximum Share Number shall be correspondingly adjusted. 

For the avoidance of doubt, (x) once the Company reaches the Common Equity Issuance Cap for a Deferral Period, the Company will not be required
to issue more Common Stock (or Qualifying Warrants if the definition of Qualifying APM Securities has been modified to exclude Common Stock) with respect to deferred interest attributable to the first five years of such Deferral Period pursuant to
this Section 2.7, even if the amount referred to in clause (i) of this Section 2.7 subsequently increases because of a subsequent increase in the Current Stock Market Price of Common Stock or the number of outstanding shares of Common
Stock, and (y) so long as the definition of Qualifying APM Securities has not been amended to eliminate Common Stock, the sale of Qualifying Warrants to pay deferred interest is an option that may be 

  

 -17- 

 
exercised at the Company’s sole discretion and the Company is not obligated to sell Qualifying Warrants or to apply the proceeds of any such sale to pay
deferred interest on the JSNs, and no class of investors of the Company’s securities, or any other party, may require the Company to issue Qualifying Warrants. 
 (b)        Market Disruption Event and Supervisory Event. Section 2.7(a) will not
apply with respect to any Interest Payment Date if the Company shall have provided to the Trustee (and to the Property Trustee of the Trust to the extent the Trust is the sole Holder of the JSNs) no more than 15 and no less than 10 Business Days
before such Interest Payment Date an Officers’ Certificate stating that (i) a Market Disruption Event or Supervisory Event was existing after the immediately preceding Interest Payment Date and (ii) either (x) the Market
Disruption Event or Supervisory Event continued for the entire period from the Business Day immediately following the preceding Interest Payment Date to the Business Day immediately preceding the date on which such Officers’ Certificate is
provided or (y) the Market Disruption Event or Supervisory Event continued for only part of such period but the Company was unable to raise sufficient Eligible Proceeds during the rest of that period to pay all accrued and unpaid interest due
on the Interest Payment Date with respect to which such Officers’ Certificate is being delivered or (z) the Supervisory Event prevents the Company from applying the net proceeds of sales of Qualifying APM Securities to pay deferred
interest on such Interest Payment Date. 
 (c)        Partial Payment of Deferred
Interest. 
 (i)        If the Company has raised some but not all Eligible
Proceeds necessary to pay all deferred interest on any Interest Payment Date pursuant to this Section 2.7, such Eligible Proceeds will be allocated to pay accrued and unpaid interest on the applicable Interest Payment Date in chronological
order based on the date each payment was first deferred, subject to the Common Equity Issuance Cap and the Preferred Stock Issuance Cap, and payment on each installment of deferred interest will be distributed to Holders of such installment on a
pro rata basis. 
 (ii)        If the Company has outstanding Parity
Securities under which the Company is obligated to sell securities that are Qualifying APM Securities and apply the net proceeds to the payment of deferred interest or distributions, then on any date and for any period the amount of net proceeds
received by the Company from those sales and available for payment of the deferred interest and distributions will be applied to the JSNs and those other Parity Securities on a pro rata basis up to the Maximum Share Number, the Common Equity
Issuance Cap and the Preferred Stock Issuance Cap (or comparable provisions in the instruments governing those other Parity Securities) in proportion to the total amounts that are due on the JSNs and such other Parity Securities, or on such other
basis as the Federal Reserve may approve. The Company may make such pro rata payments on such Parity Securities so long as it shall have paid or deposited with the Paying Agent for the JSNs or segregated and holds in trust for payment the
pro rata amount of deferred interest payable on the JSNs. 
 (d)        Qualifying APM Securities Definition Change. The Company will send written notice to the Trustee (which notice the Trustee will promptly forward upon receipt to the Administrative
Trustees, who will forward such notice to each holder of record of Trust Preferred Securities) prior to the effective date of any change in the definition of Qualifying APM Securities to eliminate Common Stock or Qualifying Warrants. 
  

 -18- 

 Section 2.8.        Redemption of the JSNs 
 (a)    Redemption. Section 11.7 of the Indenture shall not apply to the JSNs. The JSNs shall be
redeemable, at the Company’s option, at any time, including on or after the Scheduled Maturity Date. The redemption price shall be 100% of the principal amount of JSNs being redeemed, plus accrued and unpaid interest through the Redemption
Date, in the case of any redemption (i) in whole or in part on April 15, 2017 or April 15, 2027 (or if either such day is not a Business Day, on the next Business Day); (ii) in whole but not in part at any time within 90 days
after the occurrence of a Capital Treatment Event or Investment Company Event; (iii) in whole but not in part at any time after April 15, 2017 and within 90 days after the occurrence of a Tax Event; or (iv) in whole or in part at any
time on or after April 15, 2037. In all other cases, the redemption price will equal the applicable Make-Whole Redemption Price. The Company will notify the Trust of the applicable Make-Whole Redemption Price (if applicable) promptly after the
calculation thereof and the Trust will have no responsibility for calculating the Make-Whole Redemption Price. The Company may not redeem the JSNs in part if the principal amount of the JSNs has been accelerated and such acceleration has not been
rescinded unless all accrued and unpaid interest including deferred interest has been paid in full on all outstanding JSNs for all Interest Periods terminating on or before the Redemption Date. Notice of any redemption will be mailed at least thirty
(30) days but not more than sixty (60) days before the redemption date to each holder of JSNs to be redeemed at its registered address. 
 (b)    Sinking Fund. The JSNs are not entitled to any sinking fund payments or similar provisions. 
 Section 2.9.         Events of Default 
 (a)    Paragraphs (1) through (5) of Section 5.1 of the Indenture will not apply to the JSNs, the occurrence of an event described therein will not be an Event of Default with respect to the JSNs, and such
paragraphs are replaced with the following subparagraphs (i) through (iv), the occurrence of any of which shall be an Event of Default with respect to the JSNs. 
 (i)    the default in the payment of interest, including Additional Interest, in full on the JSNs for a period of 30
days after the conclusion of a 10-year period following the commencement of any Deferral Period; 
 (ii)    the entry of a decree or order by a court having jurisdiction in the premises adjudging the Company a bankrupt or insolvent, or approving as properly filed a petition seeking reorganization, arrangement,
adjustment or composition of or in respect of the Company under any applicable Federal or State bankruptcy, insolvency, reorganization or other similar law, or appointing a receiver, liquidator, assignee, trustee, sequestrator (or other similar
official) of the Company or of any substantial part of its property or ordering the winding up or liquidation of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days;

 (iii)    the institution by the Company of proceedings to be adjudicated a bankrupt or insolvent, or
the consent by it to the institution of bankruptcy or insolvency proceedings against it, or the filing by it of a petition or answer or consent seeking reorganization or relief under any applicable Federal or State bankruptcy, insolvency,
reorganization or other similar law, or the consent by it to the filing of any such petition or to the appointment of a receiver, liquidator, assignee, trustee, sequestrator (or other similar 

  

 -19- 

 
official) of the Company or of any substantial part of its property, or the making by it of an assignment for the benefit of creditors, or the admission by
it in writing of its inability to pay its debts generally as they become due and its willingness to be adjudicated a bankrupt, or the taking of corporate action by the Company in furtherance of any such action; 
 (iv)    a receiver is appointed for a Major Subsidiary Depository Institution under the Federal Deposit Insurance Act
or other applicable law. 
 (b)    The JSNs shall not have the benefits of Section 5.3 of the
Indenture. 
 (c)    So long as any JSNs are held by or on behalf of the Trust, the Trustee will provide
to the holders of the Trust Preferred Securities such notices as it will from time to time provide under Section 6.2 of the Indenture. In addition, the Trustee will provide to the holders of the Trust Preferred Securities notice of any Event of
Default or event that, with the giving of notice or lapse of time, or both, would become an Event of Default with respect to the JSNs within 30 days after the actual knowledge of a Responsible Officer of the Trustee of such Event of Default or other
event. 
 (d)    For the avoidance of doubt, and without prejudice to any other remedies that may be
available to the Trustee, the Holders of the JSNs or the holders of the Trust Preferred Securities under the Indenture, no breach by the Company of any covenant or obligation under the Indenture or the terms of the JSNs will be an Event of Default
with respect to the JSNs other than those specified as Events of Default in Section 2.9(a). 
 (e)    The Company shall not enter into any supplemental indenture with the Trustee to add any additional event of default with respect to the JSNs to the definition of Event of Default without the consent of the Holders
of at least a majority in aggregate principal amount of outstanding JSNs. 
 Section
2.10.        Securities Registrar; Paying Agent; Delegation of Trustee Duties 
 (a)    The Company appoints Wilmington Trust Company as Securities Registrar and Paying Agent with respect to the JSNs. 
 (b)    Notwithstanding any provision contained herein, to the extent permitted by applicable law, the Trustee may delegate its duty to provide such notices and to perform such other duties as may
be required to be provided or performed by the Trustee under the Indenture, and, to the extent such obligation has been so delegated, the Trustee will not be responsible for monitoring the compliance of, nor be liable for the default or misconduct
of, any such designee. 
 Section 2.11.        Limitation on Claims in the Event of Bankruptcy,
Insolvency or Receivership 
 Each Holder, by such Holder’s acceptance of the JSNs, agrees that if a Bankruptcy Event of the Company
shall occur before the redemption or repayment of such JSNs, such Holder shall have no claim for, and thus no right to receive, any deferred interest pursuant to Section 2.5 that has not been paid pursuant to Sections 2.5 and 2.7 to the extent
the amount of such interest exceeds the sum of (x) two years of accumulated and unpaid interest on such Holder’s JSNs and (y) an amount equal to such Holder’s pro rata share of the excess, if any, of the Preferred Stock
Issuance Cap over the aggregate amount of net proceeds from the sale of Qualifying Preferred Stock that the Company has applied to pay such deferred interest pursuant to the Alternative Payment Mechanism. Each Holder of JSNs shall be deemed to agree
that, to the 

  

 -20- 

 
extent the remaining claim exceeds the amount set forth in clause (x), the amount it receives in respect of such excess shall not exceed the amount it would
have received the claim for such excess ranked pari passu with the interests of the Holders, if any, of Qualifying Preferred Stock. 
 Section 2.12.        Unconditional Right of Holders to Receive Principal, Premium and Interest; Direct Action by Holders of Trust Preferred Securities. 
 Section 5.8 of the Indenture will not apply to the JSNs. 
 Notwithstanding any other provision in the Indenture, each Holder of the JSNs shall have the right, which is absolute and unconditional, to receive payment of the principal of (and premium, if any) and (subject to
Section 3.8 of the Indenture) interest (including any Additional Interest) on the JSNs on the Final Repayment Date (or, in the case of redemption or repayment, on the Redemption Date or the Repayment Date, as the case may be) and to institute
suit for the enforcement of any such payment, and such right shall not be impaired without the consent of such Holder. So long as any JSNs are held by or on behalf of the Trust, any holder of the Trust Preferred Securities issued by the Trust shall
have the right, upon (i) the breach by the Company of its obligations under Section 2.2(a)(v) to issue Qualifying Capital Securities or Section 2.7(a) to issue Qualifying APM Securities or (ii) the occurrence of an Event of
Default described in Section 2.9(a), to institute a suit directly against the Company (a) in the case of (i) above, to enforce such obligations or for such other remedies as may be available and (b) in the case of
(ii) above, for enforcement of payment to such Holder of principal of (premium, if any) and (subject to Section 3.8 of the Indenture) interest (including any Additional Interest) on the JSNs having a principal amount equal to the aggregate
Liquidation Amount (as defined in the Amended Declaration) of such Trust Preferred Securities. 
 ARTICLE III 
 REPAYMENT OF JSNS 
 Section 3.1.        Repayments 
 The Company will, not less
than 30 nor more than 10 Business Days before each Repayment Date (unless a shorter notice will be satisfactory to the Trustee), notify the Trustee of the principal amount of JSNs to be repaid on such date pursuant to Section 2.2(a).

 Section 3.2.        Selection of the JSNs to be Repaid 
 If less than all the JSNs are to be repaid on any Repayment Date (unless the JSNs are issued in the form of a Global Security or held by the Property
Trustee), the particular JSNs to be repaid will be selected not more than 60 days before such Repayment Date by the Trustee, from the Outstanding JSNs not previously repaid or called for redemption, by lot or such other method as the Trustee will
deem fair and appropriate and which may provide for the selection for redemption of a portion of the principal amount of any JSNs; provided that the portion of the principal amount of any JSNs not repaid will be in an authorized denomination
(which will not be less than the minimum authorized denomination). 
 The Trustee will promptly notify the Company in writing of the JSNs
selected for partial repayment and the principal amount thereof to be repaid. For all purposes hereof, unless the context otherwise requires, all provisions relating to the repayment of JSNs will relate, in the case of any JSNs repaid or to be
repaid only in part, to the portion of the principal amount of such JSNs that has been or is to be repaid. JSNs registered in the name of the Company, any Affiliate or any Subsidiary thereof will not be included in the JSNs selected for repayment
except to the extent no other JSNs remain or would remain outstanding. 
  

 -21- 

 Section 3.3.        Notice of Repayment 
 Notice of repayment will be given by first-class mail, postage prepaid, mailed more than 10 and not less than 30 Business Days before the Repayment Date,
to each Holder of JSNs to be repaid, at the address of such Holder as it appears in the Security Register. 
 Each notice of repayment will
identify the JSNs to be repaid (including CUSIP number, if a CUSIP number has been assigned to the JSNs) and will state: 
 (a)    the Repayment Date; 
 (b)    if less than all Outstanding JSNs are
to be repaid, the identification (and, in the case of partial repayment, the respective principal amounts) of the particular JSNs to be repaid; 
 (c)    that on the Repayment Date, the principal amount of the JSNs to be repaid will become due and payable upon each such JSNs or portion thereof, and that interest thereon, if any, will cease to
accrue on and after said date; 
 (d)    whether any deferred interest shall remain outstanding on any
JSNs to be repaid, and if so, the amount of such deferred interest and that Additional Interest shall continue to accrue on and after said date until paid; and 
 (e)    the place or places where such JSNs are to be surrendered for payment of the principal amount thereof.

 Notice of repayment will be given by the Company or, at the Company’s request, by the Trustee in the name and at the expense of the
Company and will be irrevocable. The notice if mailed in the manner herein provided will be conclusively presumed to have been duly given, whether or not the Holder receives such notice. In any case, a failure to give such notice by mail or any
defect in the notice to the Holder of any JSNs designated for repayment as a whole or in part will not affect the validity of the proceedings for the repayment of any other JSNs. 
 Section 3.4.        Deposit of Repayment Amount 
 Before 10:00 a.m. New York City time on the Repayment Date specified in the notice of repayment given as provided in Section 3.3, the Company will
deposit with the Trustee or with one or more Paying Agents (or if the Company is acting as its own Paying Agent, the Company will segregate and hold in trust as provided in Section 10.3 of the Indenture) an amount of money sufficient to pay the
principal amount of, and any accrued interest on, all the JSNs that are to be repaid on that date. 
 Section
3.5.        Repayment of JSNs 
 If any notice of repayment has been given as provided in
Section 3.3, the JSNs or portion of the JSNs with respect to which such notice has been given will become due and payable on the date and at the place or places stated in such notice. On presentation and surrender of such JSNs at a Place of
Payment in said notice specified, the said securities or the specified portions thereof will be paid by the Company at their principal amount, together with accrued interest to the Repayment Date; provided that, except in the case of a
repayment in full of all Outstanding JSNs, installments of interest whose Stated Maturity is on or before the Repayment Date will be payable to the Holders of such JSNs, or one or more Predecessor Securities, registered as such at the close of
business on the relevant Regular Record Dates according to their terms and the provisions of Section 3.8 of the Indenture. 
  

 -22- 

 Upon presentation of any JSNs repaid in part only, the Company will execute and the Trustee will
authenticate and make available for delivery to the Holder thereof, at the expense of the Company, a new JSNs, of authorized denominations, in aggregate principal amount equal to the portion of the JSNs not repaid and so presented and having the
same Scheduled Maturity Date and other terms as such JSNs. If a Global Security is so surrendered, such new JSNs will also be a new Global Security. 
 If any JSNs required to be repaid will not be so repaid upon surrender thereof, the principal of such JSNs will, until paid, bear interest from the applicable Repayment Date at the rate prescribed therefore in the
JSNs. 
 ARTICLE IV 
 EXPENSES 
 Section 4.1.        Expenses 
 In connection with the offering, sale and issuance of the JSNs to the Property Trustee on behalf of the Trust and in connection with the sale of the
Trust Securities by the Trust, the Company, in its capacity as borrower with respect to the JSNs, will: 
 (a)    pay, and reimburse the Trust in full for, all costs and expenses relating to the offering, sale and issuance of the JSNs, including commissions to the underwriters payable pursuant to the Underwriting Agreement
and compensation and indemnification of the Trustee under this Supplemental Indenture in accordance with the provisions of this Supplemental Indenture; 
 (b)    be responsible for and will pay, and reimburse the Trust in full for, all debts and obligations (except for any amounts owed to holders of the JSNs in their respective capacities as holders)
and all costs and expenses of the Trust (including, but not limited to, costs and expenses relating to the organization, maintenance and dissolution of the Trust), the offering, sale and issuance of the Trust Securities (including commissions to the
underwriters in connection therewith), the indemnities, fees and expenses (including reasonable counsel fees and expenses) of the Property Trustee, the Delaware Trustee, the Administrative Trustees, the Securities Registrar and the Paying Agent, the
costs and expenses relating to the operation of the Trust, including, without limitation, costs and expenses of accountants, attorneys, statistical or bookkeeping services, expenses for printing and engraving and computing or accounting equipment,
paying agent(s), registrar(s), transfer agent(s), duplicating, travel and telephone and other telecommunications expenses and costs and expenses incurred in connection with the acquisition, financing, and disposition of Trust assets and the
enforcement by the Property Trustee of the rights of the Holders of the JSNs; and 
 (c)    pay, and
reimburse the Trust in full for, any and all taxes (other than United States withholding taxes attributable to the Trust or its assets) and all liabilities, costs and other expenses with respect to such taxes of the Trust. 
 Such payment obligation includes any such costs, expenses or liabilities of the Trust that are required by applicable law to be satisfied in connection
with a dissolution of the Trust. 
 Notwithstanding any provision contained herein, Section 10.6 of the Indenture will not apply for the
purposes of the JSNs. 
  

 -23- 

 The Company’s obligations under this Section 4.1 will be for the benefit of, and will be
enforceable by, any Person to whom such debts, obligations and costs are owed (a “Creditor”) whether or not such Creditor has received notice hereof. Any such Creditor may enforce the Company’s obligations under this
Section 4.1 directly against the Company and the Company irrevocably waives any right or remedy to require that any such Creditor take any action against the Trust or any other Person before proceeding against the Company. The Company agrees to
execute such additional agreements as may be necessary or desirable in order to give full effect to the provisions of this Section 4.1. 
 ARTICLE V 
 FORM OF JSNS 
 Section 5.1.        Form of JSNs 
 The JSNs are to be substantially in the following form and will bear any legend required by Section 2.4 of the Indenture and include the
Trustee’s certificate of authentication in the form required by Section 2.5 of the Indenture: 
  

			
	 No.
 Issue Date:
	 	Principal Amount: $                    

 FIFTH THIRD BANCORP 
 6.50% JUNIOR SUBORDINATED NOTES DUE 2067 
 FIFTH THIRD BANCORP, a corporation organized and existing under the laws of Ohio (hereinafter called the “Company”, which term
includes any successor corporation under the Indenture hereinafter referred to), for value received, hereby promises to pay to                     ,
or registered assigns, the principal sum of                     
($                    ) and all accrued and unpaid interest thereof on April 1, 2067, or if such day is not a Business Day, the following
Business Day (the “Final Repayment Date”). 
 The Company further promises to pay interest on said principal sum from and
including March 30, 2007, or from and including the most recent Interest Payment Date on which interest has been paid or duly provided for, until the principal thereof is paid or made available for payment. Interest shall be payable
(i) semi-annually in arrears on April 15 and October 15 of each year, beginning on October 15, 2007 until April 15, 2017, (ii) quarterly in arrears on January 15, April 15, July 15 and October 15 of
each year, beginning on July 15, 2017 until April 15, 2047, and (iii) monthly in arrears on the 15th day of each month thereafter (each such date, an “Interest Payment Date”), at the rate of (i) 6.50% per
annum, from and including March 30, 2007 to but excluding April 15, 2017, (ii) an annual rate equal to three-month LIBOR plus 1.3675%, from and including April 15, 2017 to but excluding April 15, 2047, and (iii) an
annual rate equal to one-month LIBOR plus 2.3675% thereafter (computed on the basis of (i) a 360-day year comprised of twelve 30-day months with respect to any Interest Period ending on or prior to April 15, 2017 and (ii) a 360-day
year and the actual number of days elapsed with respect to any other Interest Period), plus Additional Interest, if any; provided, however, if any Interest Payment Date described in clauses (ii) or (iii) of this paragraph
falls on a day that is not a Business Day, the applicable Interest Payment Date shall instead occur on the immediately succeeding Business Day. Accrued interest that is not paid on the applicable Interest Payment Date (after giving effect to the
adjustments described in the last sentence of Section 2.4(b) of the Indenture), including interest deferred pursuant to Section 2.5 of the Supplemental Indenture, will 

  

 -24- 

 
bear Additional Interest, to the extent permitted by law, at the then-applicable rate described in the second sentence of this paragraph, from the relevant
Interest Payment Date, compounded on each subsequent Interest Payment Date. If any Interest Payment Date on or prior to the regularly scheduled Interest Payment Date in April, 2017 occurs on a day that is not a Business Day, the payment of interest
for such Interest Payment Date shall be made (or such interest shall be made available for payment) on the next succeeding Business Day with the same force and effect as if such payment were made on the relevant Interest Payment Date. A
“Business Day” will mean any day other than a Saturday, Sunday, or any other day on which banking institutions and trust companies in New York, New York, Wilmington, Delaware or Cincinnati, Ohio, are permitted or required by any
applicable law to close, or on or after April 15, 2017, a day that is not a London banking day. A “London banking day” means any day on which commercial banks are open for general business (including dealings in deposits in
U.S. dollars) in London, England. The interest installment so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in the Indenture, be paid to the Person in whose name this Security (or one or more
Predecessor Securities) is registered at the close of business on the Regular Record Date for such interest installment, which will be the date that is the last day of the month immediately preceding the month in which such Interest Payment Date
falls (whether or not a Business Day). Any such interest installment not so punctually paid or duly provided for (other than interest deferred in accordance with the next paragraph) will forthwith cease to be payable to the Holder on such Regular
Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the
Trustee, notice whereof will be given to Holders of Securities of this series not less than 10 days before such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange
on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 
 So long as no Event of Default has occurred and is continuing, the Company has the right at any time or from time to time during the term of this Security to defer payment of interest on this Security for one or more
consecutive Interest Periods up to 10 years; provided, however, that no Deferral Period will extend beyond the Final Repayment Date or the earlier redemption of any Securities of this series. Upon the termination of any Deferral Period and
upon the payment of all deferred interest then due, the Company may elect to begin a new Deferral Period, subject to the above requirements. Except as provided in Section 2.7 of the Supplemental Indenture, no interest will be due and payable
during a Deferral Period except at the end thereof. 
 So long as any Securities remain outstanding, if the Company has given notice of its
election to defer interest payments on the Securities but the related Deferral Period has not yet commenced or a Deferral Period is continuing, the Company will not, and will not permit any Subsidiary of the Company to, (i) declare or pay any
dividends or distributions, or redeem, purchase, acquire or make a liquidation payment with respect to any shares of the Company’s capital stock, (ii) make any payment of principal of or interest or premium, if any, on or repay, purchase
or redeem any debt securities or guarantees of the Company that rank upon the Company’s liquidation on a parity with this Security (including this Security, the “Parity Securities”), or junior in interest to this Security
(except for partial payments of interest with respect to the Security) or (iii) make any payments under any guarantee by the Company that ranks junior to the Guarantee Agreement (other than (a) any purchase, redemption or other acquisition
of shares of the Company’s capital stock in connection with (1) any employment contract, benefit plan or other similar arrangement with or for the benefit of any one or more of its employees, officers, directors or consultants, (2) a
dividend reinvestment or stockholder purchase plan, (3) transactions effected by or for the account of customers of the Company or any of its affiliates or in connection with the distribution, trading or market-making in respect of the Trust
Preferred Securities or (4) the issuance of the Company’s capital stock, or securities convertible into or exercisable for such capital stock, as consideration in an acquisition 

  

 -25- 

 
transaction entered into before the applicable Deferral Period; (b) any exchange or conversion of any class or series of the Company’s capital
stock, or the capital stock of one of its subsidiaries, for any other class or series of the Company’s capital stock, or any class or series of the Company’s indebtedness for any class or series of its capital stock; (c) any purchase
of fractional interests in shares of the Company’s capital stock pursuant to the conversion or exchange provisions of such capital stock or the securities being converted or exchanged; (d) any declaration of a dividend in connection with
any rights plan, or the issuance of rights, stock or other property under any rights plan, or the redemption or purchase of rights pursuant thereto; (e) any dividend in the form of stock, warrants, options or other rights where the dividend
stock or stock issuable upon exercise of such warrants, options or other rights is the same stock as that on which the dividend is being paid or ranks equally with or junior to such stock); (f) any payment of current or deferred interest on
Parity Securities that is made pro rata to the amounts due on such Parity Securities, provided that such payments are made in accordance with Section 2.7(c) of the Supplemental Indenture to the extent it applies, and any payments
of deferred interest on Parity Securities that, if not made, would cause the Company to breach the terms of the instrument governing such Parity Securities or (g) any payment of principal in respect of Parity Securities having the same
scheduled maturity date as this Security, as required under a provision of such Parity Securities that is substantially the same as the provision described in Section 2.2 of the Supplemental Indenture, and that is made on a pro rata
basis among one or more series of Parity Securities having such a provision). In addition, if any Deferral Period lasts longer than one year, the Company will not repurchase or acquire any securities ranking junior to or pari passu with any
of its Qualifying APM Securities the proceeds of which were used to settle deferred interest during the relevant Deferral Period before the first anniversary of the date on which all deferred interest on this Security has been paid before the first
anniversary of the date on which all deferred interest on this Security has been paid, subject to the exceptions listed above. 
 The Company
will give written notice of its election to begin or extend any Deferral Period, (x) if the Property Trustee, on behalf of the Trust, is the sole holder of the Securities, to the Property Trustee and the Delaware Trustee not more than 30 and at
least five Business Days before the earlier of (A) the next succeeding date on which the distributions on the Trust Preferred Securities are payable and (B) the date the Property Trustee is required to give notice to holders of the Trust
Preferred Securities of the record or payment date for the related distribution, or (y) if the Property Trustee, on behalf of the Trust, is not the sole Holder of the Securities, to Holders of the Securities and the Trustee at least five
Business Days before the next Interest Payment Date. 
 Payment of the principal of and interest on this Security will be made at the office
or agency of the Company maintained for that purpose in the United States, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided, however, that at
the option of the Company payment of interest may be made (i) by check mailed to the address of the Person entitled thereto as such address will appear in the Securities Register or (ii) by wire transfer in immediately available funds at
the bank account number as may be designated by the Person entitled thereto as specified in the Securities Register in writing not less than ten days before the relevant Interest Payment Date. 
 The indebtedness evidenced by this Security is, to the extent provided in the Indenture, subordinate and junior in right of payment to the prior payment
in full of all Senior Debt, and this Security is issued subject to the provisions of the Indenture with respect thereto. Each Holder of this Security, by accepting the same, (a) agrees to and will be bound by such provisions,
(b) authorizes and directs the Trustee on his behalf to take such actions as may be necessary or appropriate to effectuate the subordination so provided and (c) appoints the Trustee his attorney-in-fact for any and all such purposes. Each
Holder hereof, by his acceptance hereof, waives all notice of the acceptance of the subordination provisions contained herein and in the Indenture by each holder of Senior Indebtedness, whether now outstanding or hereafter incurred, and waives
reliance by each such holder upon said provisions. 
  

 -26- 

 Reference is hereby made to the further provisions of this Security set forth on the reverse hereof,
which further provisions will for all purposes have the same effect as if set forth at this place. 
 Unless the certificate of
authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature, this Security will not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 
 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed.

  

			
	FIFTH THIRD BANCORP
		
	 By:
	 	

		 	PRESIDENT OR VICE PRESIDENT

 Attest: 
 SECRETARY OR ASSISTANT SECRETARY 
 Trustee’s Certificate of Authentication 
 This is one of the Securities of the series designated therein referred to in the Indenture referred to hereinafter. 
  

			
	WILMINGTON TRUST COMPANY, AS TRUSTEE
		
	 By:
	 	

		 	Authorized Officer

 (FORM OF REVERSE OF JSNs) 
 This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”), issued and to be issued
in one or more series under the Junior Subordinated Indenture, dated as of March 20, 1997 (herein called the “Base Indenture”), between the Company and Wilmington Trust Company, as trustee (the “Trustee”), as
amended and supplemented by the Supplemental Indenture, dated as of March 30, 2007, between the Company and the Trustee (the “Supplemental Indenture”, and together with the Base Indenture, the “Indenture”), to
which Indenture and all other indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Trustee, the Company and the Holders of the Securities,
and of the terms upon which the Securities are, and are to be, authenticated and delivered. By the terms of the Indenture, the Securities are issuable in series that may vary as to amount, date of maturity, rate of interest, rank and in any other
respect provided in the Indenture. 
 All terms used in this Security that are defined in the Indenture or in the Amended and Restated
Declaration of Trust, dated as of March 30, 2007, as amended (the “Amended Declaration”), for Fifth Third Capital Trust IV among Fifth Third Bancorp, as Sponsor, Wilmington Trust Company, as the Property Trustee and the
Delaware Trustee, and the Administrative Trustees, will have the meanings assigned to them in the Indenture or the Amended Declaration, as the case may be. 
  

 -27- 

 This Security shall be redeemable, at the Company’s option, at any time, including on or after the
Scheduled Maturity Date. The Company may redeem this Security (i) in whole or in part on April 15, 2017 or April 15, 2027 (or if either such date is not a Business Day, on the immediately following Business Day); (ii) in whole
but not in part at any time within 90 days after the occurrence of a Capital Treatment Event or Investment Company Event; (iii) in whole but not in part at any time after April 15, 2017 and within 90 days after the occurrence of a Tax
event; or (iv) in whole or in part on or after April 15, 2037, including on or after the Scheduled Maturity Date, in each case at a redemption price equal to 100% of the principal amount of this Security to be redeemed plus accrued and
unpaid interest to the Redemption Date. In all other cases, the redemption price will equal the applicable Make-Whole Redemption Price. Securities of this series shall be subject to partial redemption only in the amount of $1,000 or integral
multiples thereof. 
 No sinking fund is provided for the Securities. 
 The Indenture contains provisions for satisfaction and discharge of the entire indebtedness of this Security upon compliance by the Company with certain
conditions set forth in the Indenture. 
 The Indenture permits, with certain exceptions as therein provided, the Company and the Trustee at
any time to enter into a supplemental indenture or indentures for the purpose of modifying in any manner the rights and obligations of the Company and of the Holders of the Securities, with the consent of the Holders of not less than a majority in
principal amount of the Outstanding Securities to be affected by such supplemental indenture. The Indenture also contains provisions permitting Holders of specified percentages in principal amount of the Securities at the time Outstanding, on behalf
of the Holders of all Securities, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security will be
conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is
made upon this Security. 
 As provided in and subject to the provisions of the Indenture, if an Event of Default (other than an Event of
Default specified in Sections 5.1(1) through 5.1(5) of the Base Indenture) with respect to the Securities at the time Outstanding occurs and is continuing, then and in every such case the Trustee or the Holders of not less than 25% in principal
amount of the Outstanding Securities may declare the entire principal amount and all accrued but unpaid interest of all the Securities to be due and payable immediately, by a notice in writing to the Company (and to the Trustee if given by Holders);
provided that, in the case of the Securities issued to and held by Fifth Third Capital Trust IV, or any trustee thereof or agent therefor, if upon an Event of Default, the Trustee or the Holders of not less than 25% in principal amount of the
Outstanding Securities fails to declare the entire principal and all accrued but unpaid interest of all the Securities to be immediately due and payable, the holders of at least 25% in aggregate Liquidation Amount of the Trust Preferred Securities
then outstanding shall have such right by a notice in writing to the Company and the Trustee; and upon any such declaration the principal amount of and the accrued but unpaid interest (including any Additional Interest); and on all the Securities
will become immediately due and payable; provided that the payment of principal and interest (including any Additional Interest) on such Securities will remain subordinated to the extent provided in Article XIII of the Base Indenture.

 So long as any Securities are held by or on behalf of Fifth Third Capital Trust IV, any holder of the Trust Preferred Securities issued by
the Fifth Third Capital Trust IV shall have the right, upon (i) the breach by the Company of its obligations under Section 2.2(a)(v) of the Supplemental Indenture to issue Qualifying Capital Securities or Section 2.7(a) of the
Supplemental Indenture to issue Qualifying APM Securities or (ii) the occurrence of an Event of Default described in Section 2.9(a) of the Supplemental Indenture, to institute a suit directly against the Company (a) in the case of
(i) above, to enforce such 

  

 -28- 

 
obligations or for such other remedies as may be available and (b) in the case of (ii) above, for enforcement of payment to such holder of
principal of (premium, if any) and (subject to Section 3.8 of the Base Indenture) interest (including any Additional Interest) on the Securities having a principal amount equal to the aggregate Liquidation Amount (as defined in the Amended
Declaration) of such Trust Preferred Securities. 
 The Holder of this Security, by such Holder’s acceptance hereof, agrees that if a
Bankruptcy Event of the Company shall occur before the redemption or repayment of such Security, such Holder shall have no claim for, and thus no right to receive, any deferred interest pursuant to Section 2.5 of the Supplemental Indenture that
has not been paid pursuant to Sections 2.5 and 2.7 of the Supplemental Indenture to the extent the amount of such interest exceeds the sum of (x) two years of accumulated and unpaid interest on this Security and (y) an amount equal to such
Holder’s pro rata share of the excess, if any, of the Preferred Stock Issuance Cap over the aggregate amount of net proceeds from the sale of Qualifying Preferred Stock that the Company has applied to pay such deferred interest pursuant
to the Alternative Payment Mechanism; provided that such Holder shall be deemed to agree that, to the extent the remaining claim exceeds the amount set forth in clause (x), the amount it receives in respect of such excess shall not exceed the
amount it would have received the claim for such excess ranked pari passu with the interests of the Holders, if any, of Qualifying Preferred Stock. 
 No reference herein to the Indenture and no provision of this Security or of the Indenture will alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and interest
on this Security at the times, place and rate, and in the coin or currency, herein prescribed. 
 As provided in the Indenture and subject to
certain limitations therein set forth, the transfer of this Security is registrable in the Securities Register, upon surrender of this Security for registration of transfer at the office or agency of the Company maintained under Section 10.2 of
the Base Indenture duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Securities Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon
one or more new Securities, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. No service charge will be made for any such registration of transfer or exchange, but
the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 
 Before
due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee will treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not
this Security be overdue, and neither the Company, the Trustee nor any such agent will be affected by notice to the contrary. 
 The
Securities are issuable only in registered form without coupons in minimum denominations of $1,000 and integral multiples thereof. As provided in the Indenture and subject to certain limitations therein set forth, Securities are exchangeable for a
like aggregate principal amount of Securities of a different authorized denomination, as requested by the Holder surrendering the same. 
 The Company and, by its acceptance of this Security or a beneficial interest therein, the Holder of, and any Person that acquires a beneficial interest in, this Security agree to treat for United States Federal income tax purposes
(i) the Securities as indebtedness of the Company, and (ii) the stated interest on the Securities as ordinary interest income that is includible in the Holder’s or beneficial owner’s gross income at the time the interest is paid
or accrued in accordance with the Holder’s or beneficial owner’s regular method of tax accounting, and otherwise to treat the Securities as described in the Prospectus. 
  

 -29- 

 The Indenture and this Security will be governed by and construed in accordance with the laws of the
State of New York. 
 This is one of the Securities referred to in the within mentioned Indenture. 
 ASSIGNMENT 
 FOR VALUE RECEIVED, the undersigned assigns and
transfers this Security to: 
  

  

  

 (Insert assignee’s social security or tax identification number) 
  

  

  

 (Insert address and zip code of assignee) 
 agent to transfer
this Security on the books of the Securities Registrar. The agent may substitute another to act for him or her. 
  

			
		
	 Dated:
	  	Signature:
		
		  	Signature Guarantee:

 (Sign exactly as your name appears on the other side of this Security) 
 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Securities Registrar, which requirements include
membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Securities Registrar in addition to, or in substitution
for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 
 ARTICLE VI 
 ORIGINAL ISSUE OF JSNS 
 Section 6.1.        Original Issue of JSNs 
 JSNs in the aggregate principal amount of $750,010,000 may, upon execution of this Supplemental Indenture, be executed by the Company and delivered to
the Trustee or an Authenticating Agent for authentication, and the Trustee or an Authenticating Agent will thereupon authenticate and deliver said JSNs in accordance with a Corporation Order. Subject to the maximum aggregate principal amount of JSNs
specified in Section 2.1, from time to time after the execution of this Supplemental Indenture, additional JSNs having the same terms (provided that such JSNs, if issued on or after the first Interest Payment Date, shall bear interest
from the most recent Interest Payment Date) may be executed by the 

  

 -30- 

 
Company and delivered to the Trustee or an Authenticating Agent for authentication, and the Trustee or an Authenticating Agent will thereupon authenticate
and deliver said JSNs in accordance with a Corporation Order. Any such JSNs shall become part of the same series as the JSNs originally issued hereunder. 
 Section 6.2.        Calculation of Original Issue Discount 
 If during any calendar year any original issue discount shall have accrued on the JSNs, the Company will file with each Paying Agent (including the Trustee if it is a Paying Agent) promptly at the end of each calendar year (i) a
written notice specifying the amount of original issue discount (including daily rates and accrual periods) accrued on Outstanding Securities as of the end of such year and (ii) such other specific information relating to such original issue
discount as may then be relevant under the Internal Revenue Code of 1986, as amended from time to time. Neither the Company nor the Trust would make actual payments on the JSNs, or on the Trust Preferred Securities, as the case may be, during a
Deferral Period. 
 ARTICLE VII 
 SUBORDINATION 
 Section 7.1.        Senior Debt 
 The subordination provisions of Article XIII of the Indenture will apply to the JSNs, except that for the purposes of the JSNs (but not for the purposes
of any other Securities unless specifically set forth in the terms of such Securities), “Senior Debt” or “Senior Indebtedness” is defined as the principal, premium, if any, unpaid interest (including interest
accruing on or after the filing of any petition in bankruptcy or for reorganization relating to the Company whether or not a claim for post-filing interest is allowed in such proceeding), fees, charges, expenses, reimbursement and indemnification
obligations, and all other amounts payable under or in respect of the types of debt generally described below: 
 (i)    debt for money the Company has borrowed; 
 (ii)    debt evidenced by
a bond, note, debt security, or similar instrument (including purchase money obligations) whether or not given in connection with the acquisition of any business, property or assets, whether by purchase, merger, consolidation or otherwise, but not
any account payable or other obligation created or assumed in the ordinary course of business in connection with the obtaining of materials or services; 
 (iii)    debt which is a direct or indirect obligation which arises as a result of banker’s acceptances or bank letters of credit issued to secure the Company’s obligations; 

(iv)    any debt of others described in the preceding clauses (i) through (iii) hereof which the Company
has guaranteed or for which the Company is otherwise liable; 
 (v)    debt secured by any mortgage,
pledge, lien, charge, encumbrance or any security interest existing on the Company’s property; 
 (vi)    the Company’s obligation as lessee under any lease of property which is reflected on the Company’s balance sheet as a capitalized lease; 
  

 -31- 

 (vii)    any deferral, amendment, renewal, extension, supplement or
refunding of any liability of the kind described in any of the preceding clauses (i) through (vi) hereof; and 
 (viii)    the Company’s obligations to make payments under the terms of financial instruments such as securities contracts and foreign currency exchange contracts, derivative instruments and other similar financial
instruments. 
 For purposes of the JSNs, senior debt and senior indebtedness will exclude the following: 
 (i)    the guarantee of the Trust Preferred Securities; 
 (ii)    any indebtedness or guarantee that is by its terms subordinated to, or ranks equally with, the JSNs and the
issuance of which, in the case of this clause (ii) only, (x) has received the concurrence or approval of the staff of the Federal Reserve Bank of Cleveland or the staff of the Federal Reserve or (y) does not at the time of issuance
prevent the JSNs from qualifying for Tier 1 capital treatment (irrespective of any limits on the amount of the Company’s Tier 1 capital) under the applicable capital adequacy guidelines, regulations, policies or published interpretations of the
Federal Reserve; and 
 (iii)    trade accounts payable and other accrued liabilities arising in the
ordinary course of business. 
 (b)    Notwithstanding the foregoing or any other provision of the
Indenture or of this Supplemental Indenture, provided that the Company is not subject to a bankruptcy, insolvency, liquidation or similar proceeding, the priority of the JSNs in right of payment as to Parity Securities is subject to the provisions
of Section 2.6 and the Company will be permitted to pay interest or principal on Parity Securities in accordance with Section 2.6. 
 Section 7.2.        Compliance with Federal Reserve Rules 
 The Company will not
incur any additional indebtedness for borrowed money that ranks pari passu with or junior to the JSNs (if then subject to Article XIII of the Indenture), except in compliance with applicable regulations and guidelines of the Federal Reserve.

 ARTICLE VIII 
 MISCELLANEOUS 
 Section 8.1.        Effectiveness 
 This Supplemental Indenture will become effective upon its execution and delivery. 
 Section 8.2.        Modification of Supplemental Indenture 
 Without the consent of any Holders of the JSNs, the Company, when authorized by a Board Resolution, and the Trustee, at any time and from time to time,
may enter into one or more indentures supplemental hereto, in form satisfactory to the Trustee, to eliminate Common Stock or Qualifying Warrants (but not both) from the definition of “Qualifying APM Securities” if the Company has been
advised in writing by a nationally recognized independent accounting firm that there is more than an 

  

 -32- 

 
insubstantial risk that the failure to do so would result in a reduction in its earnings per share as calculated for financial reporting purposes.

 Notwithstanding any other provision in the Indenture or this Supplemental Indenture to the contrary, the Company and the Trustee, without
the consent of any holder of JSNs, may enter into a supplemental indenture for the purpose of conforming the terms of the Indenture and/or this Supplemental Indenture and the JSNs to the description of the JSNs contained in the Prospectus
Supplement. 
 No modification or amendment to the Indenture will be effective against any holder without its consent that would reduce the
requirements contained in the Indenture for quorum or voting, or make any change to the subordination of the JSNs in a manner adverse to the holders. 
 Section 8.3.        Miscellaneous 
 The Company will promptly
give notice to Holders, in the manner provided for in the Indenture, of (i) any extension of the Scheduled Maturity Date pursuant to Section 2.2(a) and (ii) any amendment to the definition of “Qualifying APM Securities”
eliminating Common Stock or Qualifying Warrants pursuant to Section 8.2. 
 Section
8.4.        Successors and Assigns 
 All covenants and agreements in the Indenture, as
supplemented and amended by this Supplemental Indenture, by the Company will bind its successors and assigns, whether so expressed or not. 
 Section 8.5.        Further Assurances 
 The Company will, at its own cost and
expense, execute and deliver any documents or agreements, and take any other actions that the Trustee or its counsel may from time to time request in order to assure the Trustee of the benefits of the rights granted to the Trustee under the
Indenture, as supplemented and amended by this Supplemental Indenture. 
 Section
8.6.        Effect of Recitals 
 The recitals contained herein and in the JSNs, except the
Trustee’s certificates of authentication, will be taken as the statements of the Company, and neither the Trustee nor any Authenticating Agent assumes any responsibility for their correctness. The Trustee makes no representations as to the
validity or sufficiency of this Supplemental Indenture or of the JSNs. Neither the Trustee nor any Authenticating Agent will be accountable for the use or application by the Company of the JSNs or the proceeds thereof. 
 Section 8.7.    Ratification of Indenture 
 The Indenture as supplemented by this Supplemental Indenture, is in all respects ratified and confirmed, and this Supplemental Indenture will be deemed part of the Indenture in the manner and to the extent herein and
therein provided. 
 Section 8.8.        Governing Law 
 This Supplemental Indenture and the JSNs will be governed by and construed in accordance with the laws of the State of New York. 
  

 -33- 

 * * * * 
 This instrument may be executed in any number of counterparts, each of which so executed will be deemed to be an original, but all such counterparts will together constitute but one and the same instrument.

  

 -34- 

 IN WITNESS WHEREOF, the parties hereto
have caused this Supplemental Indenture to be duly executed as of the day and year first above written. 
  

			
	FIFTH THIRD BANCORP
		
	 By:
	 	 /s/    MAHESH SANKARAN

		 	 Name: Mahesh Sankaran

		 	Title: Treasurer

 Attest: 
  

			
		
	 By:
	 	 /s/    PAUL L. REYNOLDS

  

			
	WILMINGTON TRUST COMPANY,
		 	as Trustee
		
	 By:
	 	 /s/    J. CHRISTOPHER MURPHY

		 	 Name: J. Christopher Murphy

		 	Title: Financial Services Officer

 Attest: 
  

			
		
	 By:
	 	 /s/    MICHELE C. HARRA

		 	 Michele C. Harra
 Financial Service
Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}]]